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ABSTRACT 
The Cytotoxic, Antibacterial and Free Radical Scavenging Activities of the Crude Extracts 
of Matricaria chamomilla, Salvadora persica and Artemisia annua Revealed  
Ahmed Assem Nageeb Seddek 
 
     The discovery of drugs from natural sources has been a rapidly growing science in this 
era. Plants used for medicinal purposes have been usually studied as rich sources of 
bioactive chemical compounds that can be used as medications. Several plant-derived 
drugs have been approved so far. Cancer and infectious diseases have been common 
targets for the science of drug discovery, due to the high mortality rates caused by these 
diseases all over the world. Several plant-derived compounds are being marketed now 
as anti-cancer agents. However, finding novel antimicrobial and anti-cancer compounds 
has become an important goal to overcome the problems of existing anti-cancer and 
antimicrobial agents, such as resistance and non-selectivity. 
     In this thesis project, an attempt to find out useful biological activities of the crude 
extracts of some plants used traditionally for medicinal purposes in Saudi Arabia has 
been made. Matricaria chamomilla, Salvadora persica and Artemisia annua have been 
selected for study, based on the literature review performed. These plants were 
screened for three biological activities; anti-cancer, anti-bacterial and free radical 
scavenging activities. The experimental part of the study consisted of some common in-
vitro techniques, such as cytotoxicity and cell viability assays, disk diffusion assay and 
1,1-diphenyl-2-picryl-hydrazyl assay. In addition, the crude extract of Matricaria 
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chamomilla has undergone chemical fractionation and four solvent fractions were 
obtained using column chromatography.    
     The crude extract of Matricaria chamomilla showed a promising anti-bacterial 
activity against Escherichia coli and a very promising free radical scavenging activity that 
was comparable to ascorbic acid, an important anti-oxidant. The four solvent fractions 
obtained from that extract showed that these activities were produced by more than 
one compound belonging to different solvent fractions. In addition, the crude extract of 
Artemisia annua showed some anti-bacterial activity against Escherichia coli. The crude 
extract of Salvadora persica showed negative results for anti-cancer, anti-bacterial and 
free radical scavenging activities. Further fractionation and structure elucidation should 
be performed to isolate the molecules that might be responsible for any significant 
biological activity noticed. In addition, other cells types and strains of bacteria and other 
techniques can be used for screening in the future.      
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Chapter I 
Introduction 
1.1 History of medicinal plants 
     Throughout history, plants have been a resource that could satisfy the basic needs of 
humans, such as food, clothing, shelter, fuel and medication. Plants and their extracts 
have been the ultimate source of medications over thousands of years [1]. The oldest 
records, written on clay tablets in cuneiform, are from Mesopotamia and date from 
about 2600 BCE, while Egyptian medicine dates from about 2900 BCE, with the best 
known Egyptian pharmaceutical record being the Ebers Papyrus dating from 1500 BCE 
[2]. The Chinese Materia Medica has been documented several times, with the first 
record (Wu Shi Er Bing Fang), containing 52 prescriptions, that dates from about 1100 
BCE [3],[4]. The use of herbal medicine was not restricted to the eastern world, but it 
was also settled in the western world a long time ago. A philosopher and natural 
scientist named Theophrastus (~300 BCE) wrote a book called “History of Plants” that 
focused on the medicinal characters of herbs [1]. During the era of the Roman Empire, a 
man called Galen (130–200 CE) practiced and taught pharmacy and medicine in Rome. It 
is said that he published no less than 30 books on these subjects. He was famous for 
many complex prescriptions and formulas used in compounding drugs, sometimes 
containing dozens of ingredients, which is why this kind of prescriptions are called 
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galenicals nowadays [1]. During the middle ages, which were thought to be dark ages in 
Europe, the Saracens played the role of a bridge connecting much of the Greco-Roman 
expertise, which was expanded to include the use of their own resources, to other 
Indian and Chinese herbs that were unknown to the Greco-Roman world. The Saracens 
were the first population to establish privately owned drug stores in the 8th century. A 
Persian pharmacist, physician, philosopher and poet called Avicenna contributed much 
to the sciences of pharmacy and medicine through his works such as Canon Medicinae, 
which is regarded as a final codification of all Greco-Roman medicine [1].  
     During these ancient eras, people did not understand the pharmacological concepts 
behind these plants. The doctrine of signatures philosophy, which states that herbs that 
resemble various parts of the body can be used to treat ailments of that part of the 
body, was the rule that determined the uses of medicinal plants. For example, 
goldenrod with a yellow hue was used to cure jaundice, red-colored herbs were used to 
treat blood diseases, liverworts were used for liver diseases, pileworts for hemorrhoids, 
and toothworts for toothache [5]. In 1805, morphine became the first pharmacologically 
active compound to be isolated in a pure form from a plant. However, the chemical 
structure of morphine was not revealed until 1923 [5]. During the 19th century, 
numerous alkaloids were isolated from plants and used as drugs, namely, atropine 
(Atropa belladonna), caffeine (Coffea arabica), cocaine (Erythroxylum coca), ephedrine 
(Ephedra species), morphine and codeine (Papaver somniferum), pilocarpine (Pilocarpus 
jaborandi), physostigmine (Physostigma venenosum), quinine (Cinchona cordifolia), 
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salicin (Salix species), theobromine (Theobroma cacao), theophylline (Camellia sinensis), 
and (+)-tubocurarine (Chondodendron tomentosum) [5]. Following these discoveries, 
several bioactive compounds were isolated from several other plants for medicinal 
purposes. By the end of the 19th century, the basics of synthetic organic chemistry were 
understood, which lead to the appearance of the first derivatives of natural products, 
such as diacetylmorphin in 1898 and acetylsalicylic acid in 1899 [1].   
     Plants have also been used for additional purposes, such as arrow and dart poisons 
for hunting, poisons for murder, hallucinogens used for ritualistic purposes, stimulants 
for endurance, hunger suppression and cosmetics [6]. Arrow and dart poisons have 
been widely used by indigenous people in certain parts of the world. The active 
constituents were derived from the genera Aconitum (Ranunculaceae), Akocanthera 
(Apocynaceae), Antiaris (Moraceae), Chondrodendron (Menispermaceae), Strophanthus 
(Apocynaceae), and Strychnos (Loganiaceae). These active constituents responsible for 
the poison action belong to three chemical families, the alkaloids (e.g., strychnine from 
Strychnos species), cardiac glycosides (e.g., ouabain from Strophanthus species), and 
saponins (e.g., a monodesmoside glucoside from Clematis species) [7]. In some areas of 
the world, toxic plant extracts were used for murder, such as henbane (Hyoscyamus 
niger L.), mandrake (Mandragora officinarum L.), deadly nightshade (Atropa belladonna 
L.), and some Datura species, all of which belong to the family Solanaceae [8]. Ironically, 
many poisons that had been derived from plants and used for murder purposes in 
ancient cultures were used as medicines later for some of their desired pharmacological 
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actions. Examples include several Aconitum species that have been used as medicines at 
lower dosages, for their analgesic and anti-inflammatory properties [9]. Many plants 
were used in the past as hallucinogens for ritual purposes. However, these 
hallucinogens have been exploited as recreational drugs and accordingly may lead to 
habituation problems. Plants and compounds used for this purpose include Morton 
(N,N-dimethyltryptamine), Cannabis sativa L. (delta 9-trans-tetrahydrocannabinol), 
Datura species (scopolamine), Erythroxylum coca (cocaine), Papaver somniferum L. 
(morphine), and Salvia divinorum (salvinorin A). Like poisonous plants, these 
hallucinogenic plants have been used for the production of compounds with desired 
pharmacological actions such as sedatives and powerful analgesics [10], [11]. Some 
plants have also been used in the production of stimulant beverages (e.g., tea, coffee, 
cocoa, and cola) and intoxicants (e.g., wine, beer, and kava) in many cultures since 
ancient times. Tea (Camellia sinensis) was first discovered in ancient China (around CE 
350), while coffee (Coffea arabica L.) was initially cultivated and used in Yemen during 
the 9th century [8]. The active compounds of most of these stimulant drinks are 
methylated xanthines, such as caffeine, theophylline and theobromine [12].       
     There are approximately 40,000 to 70,000 medicinal plants that have been 
recognized and classified on a scientific basis, which means that almost 25% of all plant 
species have some sort of medicinal use somewhere in the world [13]. Statistics have 
shown that natural products are the richest source of bioactive molecules. According to 
the statistics made by Newman, only 30% of all novel molecules (of the 1184 so-called 
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novel chemical entities or NCEs) introduced into the market in the period 1981–2006 
were pure synthetic and all others were natural products or related to natural products 
[14]. These statistics also show that the number of NCEs reaching the market is 
decreasing every year [14]. According to other statistics in 1985 made by the Bulletin of 
the World Health Organization (WHO), around 80% of the world's population relied on 
medicinal plants as their primary healthcare source [6]. The WHO has also estimated 
that up to 80% of the population in Africa and the majority of the populations in Asia 
and Latin America still use medicinal plants for their primary healthcare needs [15]. In 
industrialized regions of the world, plant-based traditional medicines 
(phytotherapeutics) are termed as complementary or alternative medicine (CAM), and 
their use has increased steadily over the last 10 years [6]. In the USA, the estimated 
sales of herbal products in 2005 were $4.4 billion, which was a significant increase from 
$2.5 billion in 1995 [16].  
     However, the approaches of drug discovery from plant sources have suffered from 
some problems, such as costs. Isolation of compounds in their pure form and evaluating 
them for their pharmacological properties leading to drug discovery is a long, tedious, 
time-consuming and expensive path. Drug discovery from natural sources has become 
very expensive and time consuming (5 to 6 years in the 1980s to 15 to 22 years in the 
21st century). Two-thirds of the cost goes to the lead compounds that fail during clinical 
trials [17]. Many companies have abandoned the process of looking for bioactive 
molecules in natural sources, such as plants, due to the fact that long periods are 
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involved in discovery and preclinical and clinical trials, which require large numbers of 
volunteers (1000 to 5000 for long-term effects). That's why many pharmaceutical 
companies moved to the area of synthetic and combinatorial chemistry and 
modification of already existing molecules. New methods have been developed to 
overcome this problem, such as the High Throughput Screening (HTS) technique [18]. 
HTS system has been developed to screen for hundreds of thousands of chemical 
compounds in a short amount of time. HTS was developed in the early 1990s for the 
rapid screening of large numbers of extracts/compounds. The identification of disease-
specific targets is a must in this case. In this way, a great amount of bioactive molecules 
can be tested in a very short time. Consequently, bioactive molecules have become a 
good choice for pharmaceutical companies, enabling them to achieve their growth and 
economic viability [18]. 
1.2 Classification of plant metabolites  
     In general, plant products can be classified into two types; primary metabolites and 
secondary metabolites. Primary metabolites are those compounds produced mainly by 
photosynthesis in plants. They play important roles in several biosynthetic pathways. 
Examples include carbohydrates, proteins and fatty acids. Hence, primary metabolites 
are essential for plant growth. They can be used as industrial raw materials, foods, food 
additives such as vegetable oils, carbohydrates (sucrose, starch, pectin and cellulose) 
and proteins. On the other hand, secondary metabolites are products of primary 
metabolism. They are not involved in vital processes in plants, unlike primary 
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metabolites. Secondary metabolites are chemically more diverse than primary ones. 
Phenolic compounds, alkaloids, lignins, sterols, flavonoids, terpenes and other chemical 
classes compose the majority of secondary metabolites in plants. In most cases, 
secondary metabolites are the main sources of plant-derived pharmaceuticals and 
cosmetics, because they tend to exert physiological effects on mammalian systems [18]. 
     Secondary metabolites also can be a good source of pharmacological probes, which 
are molecules that aid researchers to understand the mechanisms of action of other 
drugs in the cells, in addition to understanding signaling pathways [6]. Genistein, an 
isoflavonoid isolated from soybean, is an example. It is an inhibitor of various protein 
kinases, which play important roles in signaling pathways inside mammalian cells [19]. A 
tetracyclic diterpenoid plant secondary metabolite called phorbol is another example. It 
is the hydrolysis product of croton oil which is extracted from the seeds of Croton 
tiglium L. [20]. Some diesters of phorbol are Protein Kinase C (PKC) activators. It means 
that they are tumor promoters. These diesters, such as 12-O tetradecanoylphorbol-13-
acetate (TPA), have been used in biomedical research as models for carcinogenesis 
promotion [6].  
1.3 New Plant-Derived Drugs Launched Since 2001         
1.3.1 Galantamine 
     Galantamine (also known as galanthamine) is an alkaloid that was isolated from 
several members of the family Amaryllidaceae, such as the Chinese medicinal herb 
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Lycoris radiata and the European Galanthus nivalis L. Galantamine exerts an inhibitory 
action on acetylcholinesterase and consequently improves cognitive function [21]. 
Galantamine was first marketed in the USA in 2001 for the symptomatic treatment of 
Alzheimer's disease. This compound is now produced by complete chemical synthesis 
[6]. Figure 1 shows the chemical structure of galantamine [6]. 
 
Figure 1.Chemical structure of galantamine. 
1.3.2 Apomorphine 
     Apomorphine, shown in Figure 2 [6], is a synthetic derivative of one of the oldest 
discoveries in the field of natural products chemistry, morphine. It was approved by the 
FDA (Food and Drug Administration) in 2004 for the treatment of Parkinson's disease, 
especially during episodes of hypomobility, which means inability to move, because it 
lacks the opioid analgesic properties of morphine [6].  
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Figure 2.Chemical structure of apomorphine. 
1.3.3 Cytisine and varenicline 
      Cytisine is a quinolizidine alkaloid that was isolated from Cytisus laburnum L. It has 
been one of the options for treating tobacco dependence in Eastern Europe during the 
last 40 years. Figure 3 (A) shows the structure of cytisine [6]. Varenicline was later 
developed based on cytisine. It was approved by the FDA in 2006 as a smoke cessation 
aid. Varenicline is a partial agonist with a high affinity for the α4β2 nicotinic 
acetylcholine receptors. It is also a full agonist at α7 neuronal nicotinic receptors [6]. 
Figure 3 (B) shows the structure of varenicline [6].   
 
Figure 3.Chemical structures of (A) cytisine and (B) varenicline. 
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1.4 Examples of plant derived compounds currently involved in clinical trials 
1.4.1 Betulinic acid 
     This compound in a triterpene that has shown anticancer, antibacterial, antimalarial, 
anti-HIV, anthelminthic, anti-inflammatory, and antioxidant properties. Betulinic acid 
selectively inhibits human melanoma in both in vitro and in vivo model systems, and 
induces apoptosis in Mel-2 human melanoma cells [22]. In the meantime, it is involved 
in phase I/II clinical trials for treatment of dysplastic melanocytic nevi, a preliminary 
symptom that may lead to melanomas of the skin, using a 20% ointment [23]. Betulinic 
acid is found in different plant sources, but the most notable one is the bark of white 
birch trees [22]. Figure 4 shows the chemical structure of betulinic acid [6]. 
 
Figure 4.Chemical structure of betulinic acid. 
1.4.2 Bevirimat 
     This compound was synthetically derived from betulinic acid as an anti-retroviral 
drug. It is dimethyl succinyl betulinic acid.  It is now in phase IIb trials for treating AIDS 
[24]. Bevirimat blocks HIV-1 maturation by interfering with the Gag processing pathway, 
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causing the virions released to be non-infectious, thus terminating the viral replication 
[6]. Figure 5 shows the chemical structure of bevirimat [6].  
 
Figure.5 Chemical structure of bevirimat. 
1.5 Examples of plant extracts approved for use or involved in clinical trials 
     In the meantime, new forms of plant-derived medicines have appeared. Each form is 
composed of more than one compound. These forms are called plant extracts 
(phytomedicines). There are some extract standardization procedures that control these 
complex mixtures [6]. The following extracts are examples: 
1.5.1 Devil's Claw (Harpagophytum procumbens DC.) 
     This plant has been used in Africa for the treatment of rheumatoid arthritis, pain 
relief and skin conditions for thousands of years [6]. One of the components of this 
extract, called harpagoside, has been shown to inhibit cyclooxygenase (COX)-2 
expression [25]. Clinical trials have shown that a Harpagophytum procumbens extract 
which contains 50–60 mg of harpagoside is effective in treating pain [6]. This extract is 
involved in phase II clinical trials [26]. 
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1.5.2 Ginkgo extracts 
     Ginkgo extracts are obtained from the dried leaves of the Ginkgo biloba L. tree, a 
unique species without close living relatives. That's why it has been described as a 
"living fossil". The standardized ginkgo extract (EGb 761) contains approximately 24% 
flavone glycosides (primarily quercetin, kaempferol, and isorhamnetin) and 6% 
terpenoid lactones [2.8–3.4% ginkgolides A, B and C, and 2.6–3.2% bilobalide [6]. In the 
USA, Ginkgo biloba extract (240 mg/day) is now undergoing phase III clinical trials for 
 decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing 
cognitive decline and functional disability, reducing incidence of cardiovascular disease, 
and decreasing total mortality [27]. 
1.5.3 Sativex 
     Sativex is a standardized extract of Cannabis sativa L. which contains an almost 1:1 
ratio of the cannabinoids, delta 9-tetrahydrocannabinol and cannabidiol. It was 
approved in Canada in 2005, as an oromucosal spray, for the treatment of neuropathic 
pain in patients suffering from multiple sclerosis [6].  
 
1.6 Treatment of cancer as a goal of plant natural products research 
     Cancer is a group of diseases and disorders that are all characterized by the 
uncontrolled proliferation and growth of cells [28]. This uncontrolled cell growth can 
lead to death [28]. There are many causes of cancer development, such as unhealthy 
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diet, tobacco smoking, exposure to chemicals and radiation and some infections. There 
are some other internal factors that can help in cancer development, such as mutations 
and abnormal immune conditions. There are many treatment options, such as surgery, 
radiation therapy, chemotherapy and hormone therapy. That's why cancer is one of the 
fast-growing health problems all over the world [28]. 7.6 million deaths (around 13% of 
all deaths in the world) in 2008 were caused by cancer [29]. It is expected that deaths 
from cancer will continue to rise to over 11 million deaths in 2030 [29]. The main types 
of cancer according to the number of deaths are: lung (1.4 million deaths), stomach (740 
000 deaths), liver (700 000 deaths), colorectal (610 000 deaths) and breast (460 000 
deaths) [29]. Searching for natural products that can be used for cancer treatment has 
been underway way since the 1960s, when Hartwell and co-workers applied 
podophyllotoxin as an anticancer agent [30]. Following this decade, a huge number of 
natural products extracted from different natural sources, such as plants, marine 
organisms and animals have been screened for the presence of cytotoxic and anti-
cancer activity [30].  
1.7 Examples of plant natural products used in cancer treatment 
1.7.1 Podophyllotoxin 
     Podophyllotoxin, a compound that belongs to the family of lignans, was first isolated 
from the North American plant Podophyllum peltatum Linnaeus (American 
podophyllum), commonly known as the American mandrake or May apple, by 
Podwyssotzki in 1880. A structurally related compound called 4-deoxypodophyllotoxin 
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having a potent cytotoxic activity was isolated from Anthriscus sylvestris and Pulsatilla 
koreana [30]. Figure 6 shows the chemical structure of podophyllotoxin  [30]. 
 
Figure 6.Chemical structure of podophyllotoxin. 
     Podophyllotoxin acts as a cytotoxic agent by inhibiting the assembly of microtubules 
and arresting the cell cycle at metaphase [30]. Podophyllotoxin is active against a wide 
range of cancer cell lines. It has proven efficacy in the treatment of Wilms tumours, 
various genital tumors, non-Hodgkin's and other lymphomas and lung cancer [30]. 
However, the use of podophyllotoxin to clinically treat neoplasms was not successful, 
because of the various side effects of the drug, such as nausea, vomiting, damage of 
normal cells and tissues, etc. For this reason, lots of structure modifications were 
performed attempting to get a more potent and a safer molecule [30]. Etoposide and 
teniposide were obtained by structure modifications. These two derivatives molecules 
are widely used for the treatment of lymphomas, acute leukaemia, testicular cancer, 
small cell lung cancer and ovarian, bladder and brain cancers [30].  
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1.7.2 Etoposide and teniposide 
     Etoposide and teniposide have a different mechanism of action than 
podophyllotoxin. They act by inhibiting DNA topoisomerase II enzyme. DNA 
topoisomerase I and topoisomerase II are two enzymes that catalyze the relaxation of 
supercoiled DNA during DNA replication [30]. Etoposide and teniposide are far less toxic 
than the parent molecule, podophyllotoxin [30]. Etoposide and teniposide are clinically 
used. However, etoposide use is associated with some problems like drug resistance and 
poor bioavailability. That's why there is a need to develop an etoposide derivative [30]. 
Figure 7 (A) shows the chemical structure of etoposide [30]. Figure 7 (B) shows the 
structure of teniposide [30]. 
 
Figure 7.Chemical structures of: (A) etoposide and (B) teniposide. 
 
1.7.3 Camptothecin 
     Camptothecin, shown in Figure 8 [30], is a naturally occurring alkaloid that was first 
isolated from the stem wood of the Chinese ornamental tree Camptotheca acuminate 
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during the screening of thousands of plants in a search for steroids [30]. Preliminary 
studies indicated that this molecule has a potent anti-cancer effect. It has proved 
efficacy in mouse leukemia cells [30].  
 
Figure 8.Chemical structure of camptothecin. 
     Camptothecin is considered a potent anti-cancer agent. It acts by inhibiting DNA 
topoisomerase I. It is selectively cytotoxic to S-phase cells, arrests cells in the G-2 phase 
and induces fragmentation of chromosomal DNA [30]. It showed strong anti-cancer 
activity mainly against colon and pancreatic tumors [30]. Evaluation of camptothecin as 
a drug for the treatment of colon cancer continued in the 1970s. This molecule showed 
strong anti-cancer activity against gastrointestinal tumors in clinical trials. However, it 
also caused unpredictable and severe adverse effects like myelosuppression, vomiting, 
diarrhea, and severe hemorrhagic cystitis. Consequently, phase II trials were 
discontinued in 1972 [30]. That's why different groups of researchers tried to modify the 
structure of camptothecin to get more potent and less toxic derivatives. Two water 
soluble derivatives of camptothecin were proved to be potent and less toxic; irinotecan 
and topotecan (Figure 9 [30]). They are now marketed as drugs [30].  
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Figure 9.Chemical structures of (A) irinotecan and (B) topotecan. 
     Water insoluble derivative of camptothecin, i.e. IDEC-132 (9-amino camptothecin or 
9-AC, 6) also show stronger activity against solid tumors. All these analogues work by 
the same mechanism of action, which is the inhibition of DNA topoisomerase I, but with 
less toxic effect [30]. Figure 10 shows the chemical structure of 9-amino camptothecin 
[30].  
        
 
 
 
Figure 10.Chemical structure of 9-amino camptothecin. 
1.7.4 Taxol 
     The pacific yew, Taxus brevifolia, is the original source from which taxol was 
extracted by the research group of Dr. Wall and Dr. Wani in the late 1960s in attempt 
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search for anti-neoplastic agents [30]. Chemically, taxol is a polyoxygenated diterpenoid. 
During clinical trials, taxol showed good results as a treatment for lung, ovarian and 
breast cancers and squamous cell carcinoma of the head and neck [30]. Later, the FDA 
approved taxol for the treatment of drug refractory metastatic ovarian cancer in 1992 
[30]. Taxol acts by a unique mechanism of action. Unlike many other anti-neoplastic 
agents that act by destabilizing microtubules, taxol stabilizes them [30]. Normally, 
tubulin polymerizes to microtubules and then the reverse reaction, the conversion of 
microtubules to tubulin, goes on. In normal conditions, there is some balance between 
polymerization and depolymerization. Taxol stabilizes microtubule bundles, so the cell 
lacks mitotic spindles [30]. Continuance of the cell cycle with no mitotic spindles leads to 
cell death. Taxol was marketed by Bristol-Myers-Squibb in 1992 for the treatment of 
refractory ovarian cancer, metastatic breast and lung cancer and Kaposi's sarcoma.[30] 
The chemical structure of taxol is shown in figure 11 [30]. 
 
Figure 11.Chemical structure of taxol. 
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     Despite being a good choice for the treatment of cancer, taxol has some 
disadvantages. One of the biggest disadvantages of taxol is poor water solubility, which 
means poor bioavailability. In addition, taxol has shown some side effects in many 
patients, such as numbness, nausea (quite severe in some cases), tingling in toes and 
fingers, and a reduction in white blood cell count due to taxol's effect on bone marrow. 
That's why the administration of granulocyte colony-stimulating-factor, a kind of growth 
factor, during treatment is preferable. As usual, researchers started modifying the 
structure of taxol in order to get more potent and less toxic analogues. Taxotere, shown 
in Figure 12 [30], is one of the analogues that gained a good reputation as a treatment 
for advanced metastatic breast cancer and non-small cell lung cancer. It acts by the 
same mechanism of action, however it is more potent and more water soluble than the 
parent molecule, taxol, which means that it has a higher bioavailability. However, the 
use of taxotere is also associated with some side effects, such as alopecia, bone marrow 
suppression and allergies [30].  
 
Figure 12.Chemical structure of taxotere. 
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1.8 Treatment of infectious diseases as a goal of plant natural products research 
     Infection is a situation in which a microorganism is established and growing inside a 
host. Depending on this definition, not all infections lead to disease, because growth of 
microorganisms in a host doesn't always result in diseases and damage. However, 
problems appear when infection results in damage or injury to the host. Usually, 
infections begin in the host's mucous membranes, which are composed of tightly 
packed epithelial cells. Infection proceeds if the invading microorganisms tightly adhere 
to the epithelial cells via specific cell-cell recognition between the host and the invading 
microorganism [31].   
     There are more than one million microbial species existing in nature. However, only a 
few hundred species are known to be pathogenic. There are several modes of 
transmission of infectious diseases from one person to another, such as airborne 
transmission, direct contact transmission and sexual transmission [32]. Some infectious 
microorganisms need a reservoir host, such as arthropods and animals [33]. Even 
normal flora can cause diseases to the host if the host is immunocompromised, like 
what happens in cancer and Acquired Immunodeficiency Syndrome (AIDS) [31].  
     According to statistics made by the WHO, infectious diseases are one of the main 
causes of deaths all over the world, especially in Africa. Infectious diseases were the 
cause of around 26% of the 57,029,000 total deaths that occurred in 2002 all over the 
world. Acute respiratory infections had the highest impact, followed by AIDS and 
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diarrheal diseases. In the same year, 6.7 million out of 10.7 million total deaths in Africa 
were caused by infections, giving a percentage of 63% [34]. 
     Consequently, the discovery of antimicrobial agents has been a major concern in the 
20th and the 21st centuries. Many effective antimicrobial agents have been discovered 
and marketed so far. However, there is always an existing problem that counteracts the 
discovery of new antimicrobial agents, i.e. antimicrobial drug resistance. Antimicrobial 
drug resistance is defined as the ability of a microorganism to resist the effects of an 
antimicrobial agent to which it is normally susceptible. There are different mechanisms 
of resistance to antimicrobial agents, such as altering the antimicrobial molecule to an 
inactive form inside the microorganism, modifying the target for the antimicrobial agent 
by the microorganism and pumping out the antimicrobial agent from the microorganism 
cell, which is known as efflux. Usually, resistance to antimicrobial agents is genetically 
encoded by the microorganism, either on the bacterial chromosome or on a plasmid 
that's usually referred to as the R plasmid. R plasmids can be spread among different 
strains of microorganisms, leading to the emergence of new resistant strains. To 
conclude, the discovery of new antimicrobial agents is the long lasting solution of 
resistance problems [35]. There are many strategies applied for the discovery of new 
effective antimicrobial agents, such as producing new analogues of existing 
antimicrobial agents, using computer aided drug design to design novel molecules that 
can act on very specific targets in microorganisms, using combinations of different 
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antimicrobial agents, bacteriophage therapy and screening natural products for 
antimicrobial activity [35]. 
1.9 Major groups of antimicrobial compounds from plants 
     Like animals, plants have methods to defend against infections by microorganisms. 
Plants secrete different classes of compounds, such as aromatic, phenolic and 
polyoxygenated compounds that have antimicrobial effects. Some of these compounds 
have other functions. For example, an antimicrobial plant product can be a plant 
pigment or a plant flavor [36]. These antimicrobial compounds can be divided into 
several chemical classes as follows:   
1.9.1 Phenolic and polyphenols 
1.9.1.1 Simple phenols and phenolic acids 
     Consisting of a single substituted phenolic ring, phenols and phenolic acids are 
considered as some of the simplest plant natural products. Figure 13 shows the 
chemical structure of cinnamic acid, which is an example [37]. Listeria monocytogenes 
was found to be susceptible to cinnamic acid. At a pH of 7 and a concentration higher 
than 0.5%, cinnamic acid inhibits glucose uptake and ATP synthesis in this pathogenic 
microorganism [38].     
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Figure 13.Chemical structure of cinnamic acid. 
 
1.9.1.2 Quinones 
     Quinones are a group of aromatic compounds possessing two ketone substitutions. 
Quinones play a role in pigmentation and coloring in both plants and human. Quinones 
are intermediates in the biosynthetic pathway of melanin in human. Because of the high 
reactivity of quinones, they have antimicrobial effects. They are able to complex with 
nucleophilic amino acids and proteins, such as adhesins, cell wall polypeptides and 
enzymes [36]. A quinone called hypericin, which is extracted from St. John’s wort 
(Hypericum perforatum), was found to possess general antimicrobial properties [36]. 
Figure 14 shows the chemical structure of hypericin [36]. 
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Figure 14.Chemical structure of hypericin. 
 
1.9.1.3 Flavones 
     Flavones are phenolic compounds that contain one carbonyl group. They are 
synthesized by plants in response to infections [36], which suggested that they have 
antimicrobial activities. They are thought to have the same mechanism of action of 
quinones, which is to complex with proteins and bacterial cell wall structures [36]. Two 
flavones called artocarpin and artocarpesin were isolated from Artocarpus heterophyllus 
and showed a complete growth-inhibitory effect against cariogenic bacteria and plaque 
forming streptococci [39]. Figure 15 shows the chemical structures of (A) artocarpin and 
(B) artocarpesin [39]. 
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Figure 15.Chemical structures of: (A) artocarpin and (B) artocarpesin. 
 
1.9.1.4 Tannins 
     Tannins are polymeric phenolic compounds that have the ability to tan leather, which 
is how they got their name. They are also able to precipitate gelatin from solution, 
which is called astringency. An example is pentagalloylglucose [36]. This compound was 
found to have an anti-influenza-virus activity through interacting with viral 
hemagglutinin, which is a class of viral-envelope proteins that binds to the cell 
membranes of infected host [40]. Figure 16 shows the chemical structure of 
pentagalloylglucose [36]. 
 
Figure 16.Chemical structure of pentagalloylglucose. 
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1.9.2 Terpenoids 
      Terpenoids are a group of compounds which form the majority of essential oils of 
many plants. In general, terpenoids are active against a broad spectrum of bacteria, 
viruses and protozoa. They act by disrupting the membranes of microorganisms. An 
example is betulinic acid, a triterpenoid which possesses an anti-HIV activity [36].  
1.9.3 Alkaloids 
     Alkaloids are nitrogen containing heterocyclic compounds that are found in a variety 
of plants. The first medically used alkaloid was morphine as previously mentioned. 
Berberine, shown in Figure 17 [36] is an alkaloid found in Berberis vulgaris. It was found 
that berberine is effective against trypanosomes and plasmodia through intercalating 
with the DNA of the microorganism [36]. 
 
Figure 17.Chemical structure of berberine. 
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1.10 Summary 
To summarize, finding novel antimicrobial and anti-cancer compounds has become a 
necessity to overcome the problems of existing anti-cancer and antimicrobial agents. 
These problems include resistance and non-selectivity which result in side effects to the 
patient. Throughout history, plants have been a good source for a variety of molecules 
that can be used for different medical purposes, including cancer treatment and 
overcoming infections. In addition, computer aided drug design can be used to modify 
these novel molecules and produce more potent and less toxic ones.   
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Chapter 2 
Background 
2.1 Traditional Arabic Medicine 
     Plants have been used as sources of medicines in the Arabian Peninsula for several 
centuries [18]. During the eighth century, the Arabs established drug stores that 
contained medicinal plants and their extracts as cures for different diseases [18]. A 
Persian pharmacist called Avicenna wrote a famous book about Greco-Roman medicine 
in this century [18]. That book, called "Canon of Medicine" formed the basis of healing 
systems used by Arabs and Muslims in that era [18]. Examples of medicinal plants in the 
Middle East are: Allium cepa, Astracantha gummifera, Carthamus tinctorius, Carum 
carvi, Ferula asafoetida, Lawsonia inermis, Papaver somniferum, Peganum harmala, 
Prunus dulcis, Prunica granatum, Salvadora persica, Senna alexandrina, Sesamum 
indicum, Trachyspermum ammi, Trigonella foenum-graecum and Vitis vinifera [18]. The 
following plants were selected for our research, based on their famous medicinal uses in 
the Arab world: 
2.2 Matricaria chamomilla 
     Matricaria chamomilla is an annual herbaceous plant that grows in many areas all 
over the world [41]. It has many synonyms, such as Matricaria recutita L., and 
Chamomilla recutita L [41]. It is also known as German chamomile, Hungarian 
chamomile, mayweed, sweet false chamomile or wild chamomile [41]. Flowers of the 
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plants are mainly used for medicinal purposes. Essential oils extracted from the dried or 
fresh flowers of the plant have flavoring, aromatic and coloring properties. That's why 
they are used in some industries, such as soaps, detergents, perfumes, lotions, 
ointments, hair products, baked goods, confections, alcoholic beverages and herbal teas 
[41]. Chamomile tea is used for many medicinal purposes, such as gastrointestinal tract 
ailments as flatulence, nervous diarrhea, spasms, colitis, gastritis, hemorrhoids; nasal 
mucous membrane inflammation, allergic rhinitis, attention deficit-hyperactivity 
disorder (ADHD), restlessness, insomnia, dysmenorrhea, mastitis, and varicose ulcers 
[42].  
     More than 100 constituents have been identified in the flowers of chamomile [41]. 
Mucilage, full of amino acids, fatty acids and polysaccharides, makes up 10% of the 
flower head [41]. The yield of the volatile or essential oil from the flowers is 0.4–2.0%. 
The main constituents of the oil are the terpenoids α-bisabolol and its oxides (≤78%) 
and azulenes, including chamazulene (1–15%) [41]. In addition, several phenolic 
compounds have been identified in the flower heads of chamomile, such as apigenin, 
quercetin, patuletin, luteolin, cinnamic acid derivatives ferulic and caffeic acid, as well as 
other unidentified phenolic derivatives [41]. 
     Several in-vitro studies were conducted to test for the biological activities of 
chamomile extracts [41]. It was determined that the antioxidant activity of chamomile 
was low (<18 mmol/100 g) in comparison with other medicinal and culinary herbs, by 
using the ferric reducing ability of plasma (FRAP) assay [43]. Chamazulene, shown in 
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Figure 18 [44], is a compound extracted from chamomile that inhibited Fe2+/ascorbate-
induced lipid peroxidation [45]. This inhibition was measured with the thiobarbituric 
acid reactive substances (TBARS) assay [45]. In the same study, chamazulene (25 mM) 
inhibited the auto-oxidation of dimethyl sulfoxide (DMSO) (33 mM) by 76% [45]. In 
addition, chamomile was reported to have anti-platelet activity [46]. Chamomile 
inhibited platelet aggregation induced by ADP (60%) and collagen (84%), as well as 
whole blood aggregation induced by collagen (30%) [46]. The underlying mechanism of 
action was thought to be the inhibition of thromboxane B2 synthesis which is induced 
by either ADP or collagen [46]. Apigenin, a compound extracted from chamomile, 
demonstrated in-vitro anti-inflammatory activity by interfering with leukocyte adhesion 
and adhesion protein upregulation in human endothelial cells [41]. It also inhibited 
interleukin-1 (IL-1) α-induced prostaglandin synthesis, tumor necrosis factor (TNF)- α-
induced IL-6 and IL-8 production, and blocked adhesion of leukocytes to cytokine-
treated endothelial cells [41]. 
 
Figure 18.Chemical structure of chamazulene. 
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In addition, many in-vivo studies were conducted to look for further biological effects of 
chamomile [41]. The genotoxic effect of the mutagenic agents daunorubicin and methyl 
methane sulfonate (MMS) in mouse bone marrow was attenuated by chamomile 
essential oil in one study [47]. In another study, chamomile extract showed a lowering 
effect on serum cholesterol levels in hyperlipidemic Wistar rats [48]. In a third study, the 
topical application of chamomile was tested for its effectiveness on skin tumorigenesis 
in mice. The application of 20 μM apigenin could attenuate tumorigenesis initiated by 
7,12- dimethylbenz(a)anthracene (DMBA) and promoted by TPA in SENCAR mice [49]. 
Figure 19 shows the structure of apigenin [50].  
 
Figure 19.Chemical structure of apigenin. 
     Despite having many favorable biological actions, chamomile has shown some 
adverse reactions and toxicities [41]. Severe allergic reactions to chamomile were 
reported, especially in those patients who are hypersensitive to other plants belonging 
to the same family (Astraceae or Compositae) [41]. Contact dermatitis has been 
reported in cases of oral and topical uses [41]. Some patients who applied chamomile 
tea, either as a compress or rinse, to their eyes reported conjunctivitis [41]. Coumarin, a 
constituent of chamomile, is thought to interact with warfarin therapy and potentiate it, 
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due to the anti-platelet activity of chamomile [41]. In addition, chamomile is thought to 
increase the CNS depressant effects of sedative drugs such as opioid analgesics, 
benzodiazepines or alcohol, due to its sedative effect [41].     
2.3 Salvadora persica 
Salvadora Persica is commonly called the Arak tree in the Arab World [51]. Miswak is a 
natural toothbrush made from the twigs of that plant that belongs to the family 
Salvadoraceae [51]. It has been used for centuries in the Arabian Peninsula for 
strengthening the gum, preventing tooth decay, attenuating toothaches, creating a nice 
mouth smell and eliminating bad mouth odors [51]. Salvadora persica is a large much-
branched, evergreen shrub or a tree that grows in dry and arid regions and also in 
coastal regions too. Twigs are not the only part of the plant used. In tropical Africa, 
people eat the leaves as vegetables and prepare sauces and fermented drinks from 
them [51]. Traditionally, people make a decoction of the roots and apply it for 
treatment of gonorrhea [51]. The leaves are used in piles, scabies, leucoderma, ozoena, 
and other nose troubles. For cough and asthma, a decoction of leaves is used [51]. A 
poultice made out of them is used to treat piles and tumors. In addition, leaves and 
seeds oil are used to treat rheumatism [51].  
Some compounds were isolated from Salvadora persica, such as four benzylamides 
which were identified as: butanediamide, N1, N4 -bis(phenylmethyl)-2(S)-hydroxy-
butanediamide, N-benzyl-2-phenylacetamide, N-benzylbenzamide and benzylurea [51]. 
In addition, this plant contains some fatty acids, such as oleic, linoleic and stearic acids. 
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Some terpenoids and esters of fatty acids were identified in that plant [51]. The 
essential oil of Salvadora persica contains four main constituents: 1,8-cineole 
(eucalyptol) (46%), a-caryophellene (13.4%), b-pinene (6.3%), and 9-epi-(E)-
caryophellene [51]. The volatile oil of the plant is composed of benzyl nitrile, eugenol, 
thymol, isothymol, eucalyptol, isoterpinolene, and b-caryophyllene as the major 
constituents [51]. The stem of Salvadora persica contains the flavonoids rutin and 
quercetin [51]. Figure 20 shows the chemical structure of salvadoricine, an indole 
alkaloid that was isolated from the leaves [52]. 
 
Figure 20.Chemical structure of salvadoricine [52].  
    Salvadora persica has been an interesting plant to screen for biological activity. In 
some experiments, it was shown that miswak possesses anti-dental caries and 
antiplaque activities as traditionally believed by people in the Arab World [51]. In one 
study, the efficacy of miswak in the prevention of dental caries was compared with the 
efficacy of ordinary toothbrush and toothpaste [53]. At the end of the study, the data 
collected showed that the risk of dental caries for each tooth in the control group (using 
ordinary toothbrush and toothpaste) was 9.35 times more than the case group (using 
miswak) [53]. In another study, the extract of miswak elevated the pH of plaque and 
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stimulated parotid gland secretion, which suggested the potential role of miswak in 
dental caries prevention [54].      
     In addition, many other experiments and studies showed that Salvadora persica 
possesses different biological activities. In one study, the aqueous extract of miswak 
showed fungistatic effect at a concentration of 15%. In the same study, the extract 
showed antimycotic effect that was suggested to be due to the root contents, such as 
chlorine, trimethylamine, alkaloid resin, and sulfur compounds [55]. In a second study, 
Salvadora persica stem decoction lowered the plasma levels of LDL (Low Density 
Lipoproteins) and cholesterol in diet-induced rat hypercholesterolemia [56]. In another 
study, the oil of Salvadora persica was tested for tick-repellant properties using host-
seeking nymphs of Ixodes ricinus. Significant tick-repellant activity was observed in this 
experiment [57]. In addition, the extract of root and branches of S. persica was tested 
for analgesic activity in mice. It was found that the extract possesses relatively moderate 
analgesic effect, which might be due to interaction with the central and/or peripheral 
opiate system [58]. Another in-vitro screening has reported that Salvadora persica has 
an ACE (Angiotensin Converting Enzyme) inhibitor effect, which means that it has a 
lowering effect on blood pressure [59]. Salvadora persica was also investigated for anti-
ulcer effect [60]. The decoction of the plant was tested for anti-ulcer activity in acetyl 
salicylic acid-induced ulcer in rats, by treating the rats once daily for seven days with the 
lyophilized decoction of the plant [60]. The ulcer index significantly decreased in the 
sample group [60].        
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     Concerning antibacterial activity, a study was conducted to test for the antibacterial 
effect of the aqueous and methanol extracts of Salvadora persica against seven isolated 
oral pathogens: Staphylococcus aureus, Streptococcus mutans, Strep. faecalis, Strep. 
pyogenis, Lactobacillus acidophilus, Pseudomonas aeruginosa, and Candida albicans 
[61]. Using disc diffusion and microwell dilution assays, the aqueous extract inhibited all 
isolated microorganisms, and was more efficient than the methanol extract, which was 
resisted by L. acidophilus and Pseudomonas aerogenosa [60]. Both methanol and 
aqueous extracts had the same effect on Candida albicans [61]. In another study, a 
significant antibacterial effect of miswak pieces without extraction was noticed against 
P. gingivalis, A. actinomycetemcomitans, and H. influenza [62]. In the same study, 
miswak embedded in agar, or suspended above the agar plate, had strong antibacterial 
effects against all bacteria tested, which suggests the presence of antibacterial 
compounds in the volatile oil of miswak [62]. In a different study, miswak mouthwash 
was tested for cytotoxic activity using cultured human and mouse cell lines [63]. The 
mouthwash was reported to be toxic to macrophage, epithelial, fibroblast, and 
osteoblast cells in a concentration-dependent manner [63].  
2.4 Artemisia annua 
     Artemisia annua belongs to the Artemisia genus, which contains more than 500 
species that are distributed all over the world, especially in the northern hemisphere 
[64]. Artemisia annua is commonly named as sweet wormwood or qinghao [65]. This 
herb/shrub is native to Asia [65]. Artemisia annua has been known to be an anti-
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malarial plant, especially in areas where patients cannot afford effective anti-malarial 
drugs [66]. In addition, it has been traditionally used as anti-inflammatory, antitumor 
and allelopathic [67]. A famous anti-malarial compound, called artemisinin, has been 
isolated from different species of Artemisia, including Artemisia annua [68].  
Artemisinin, also known as called qinghaosu, is a sesquiterpene lactone that possesses a 
peroxide group. It lacks a nitrogen-containing heterocyclic ring system unlike most other 
anti-malarials [69]. This compound has been successfully used for the treatment of both 
chloroquine resistant and chloroquine sensitive malaria [69]. Derivatives of qinghaosu, 
such as dihydroqinghaosu, artemether, and the water-soluble sodium artesunate, were 
proven to be more potent than artemisinin itself [69]. Figure 21 shows the chemical 
structure of artemisinin [69]. Sodium artesunate acts rapidly to restore consciousness of 
comatose patients suffering from cerebral malaria [69]. Because peroxide radicals act as 
a potent source of reactive oxygen species, the peroxide group found in this compound 
suggests its mechanism of action [70]. It is suggested that artemisinin reacts with 
intraparasitic heme, which converts the molecule into toxic free radicals, which attack 
intraparasitic targets by alkylation [70]. The malaria parasite is rich in heme that is 
obtained from the proteolysis of the host's hemoglobin [70]. The selectivity of 
artemisinin to parasites can be explained by this theory [70]. In clinical studies, 
artemisinin appears to have no serious side effects [70]. In addition, it appears to be 
safe for pregnant women [70]. However, it was proved that high doses of artemisinin 
could induce neurological problems and neurotoxicity [70]. The suggested mechanism of 
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toxicity is similar to the mechanism of anti-malarial action, because heme potentiates 
the toxicity of artemisinin derivatives to neuronal cells in vitro [70]. 
 
Figure 21.Chemical structure of artemisinin. 
     Artemisia annua and artemisinin derivatives have shown other beneficial biological 
activities. In one study, artesunate, which is a semisynthetic compound derived from 
artemisinin, showed a significant concentration-dependent increase in DNA damage 
index and a significant increase in the frequency of apoptosis and necrosis of cultured 
human lymphocytes, which suggests that this compound has cytotoxic and genotoxic 
potential [71]. In another study, the crude alcoholic extract of Artemisia annua showed 
anthelmintic activity against Schistosoma mansoni and Echinostoma caproni [72]. A third 
study showed that the essential oil of the plant, which consists of camphor (44%), 
germacrene D (16%), trans-pinocarveol (11%), β-selinene (9%), β-caryophyllene (9%) 
and artemisia ketone (3%), showed antibacterial effect against Enterococcus hirae, 
Candida albicans and Saccharomyces cerevisiae [67]. 
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Chapter 3 
Experimental 
3.1 Chemicals 
     The solvents used, i.e. methanol and ethanol, were HPLC grade. Absolute ethanol and 
Hybri-Max grade dimethyl sulphoxide (DMSO) (Sigma-Aldrich). Absolute methanol 
(Fisher Scientific). Pure distilled water was obtained by filtration through a Milli-Q 
Integral Water Purification System( Millipore).  
     The medium used for growing cell lines was Dulbecco's Modified Eagle's Medium 
(DMEM) ( 1000 mg glucose/liter, L-glutamine, sodium bicarbonate and pyridoxine 
hydrochloride) (Sigma-Aldrich). For growing primary cells, Fibroblast Growth Medium 
was used. It was supplied by Genlantis. Fetal Bovine Serum Heat Inactivated (Sigma-
Aldrich). 1 X Trypsin solution containing 2.5 grams porcine trypsin per liter in Hank's 
Buffered Salt Solution (HBSS) and was used to detach cells (Sigma-Aldrich). 10 X 
Phosphate Buffer Solution (PBS) (Sigma-Aldrich). AlamarBlue indicator was used for cell 
viability assay, (Invitrogen). LDH Cytotoxicity Detection Kit was used for cytotoxicity 
assays, (TaKaRa). The kit included two reagents, solution A: a catalyst (diaphorase/NAD+, 
lyophilisate) and solution B: a dye (iodotetrazolium chloride and sodium lactate). Triton® 
X-100 (Sigma-Aldrich). In addition, a LIVE/DEAD Viability/Cytotoxicity Kit (Invitrogen). 
The kit was composed of two components, component A: Calcein AM in anhydrous 
DMSO and component B: Ethidium homodimer-1 in DMSO/water 1:4 (v/v). 
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      For detection of antibacterial activity, Luria Agar (tryptone (pancreatic digest of 
casein) 10 g/L, yeast extract 5 g/L, sodium chloride 10 g/L and agar 15 g/L) was used 
(Sigma-Aldrich). . In addition, Difco LB Broth, Miller (Luria-Bertani) (tryptone 10 g/L, 
yeast extract 5 g/L, sodium chloride 10 g/L and agar 15 g/L) (BD). . Research grade 
kanamycin monosulphate powder and ampicillin trihydrate powder were (Fisher 
Scientific).    
     For detection of antioxidant activity, BioUltra L-ascorbic acid (Sigma-Aldrich) and 2,2-
Diphenyl-1-picrylhydrazyl (free radical), 95% (Alfa Aesar).              
3.2 Materials 
     For extraction of plant material, 250 ml and 500 ml flat bottom Erlenmeyer flasks 
were used. For evaporation of solvent using the rotary evaporator, 50 ml, 100 ml, 250 
ml and 500 ml round bottom flasks were used. Filtration was accomplished using grade 
1 Whatman filter papers with a pore size of 11 µm and durapore membrane filters 
having a pore size of 0.22 µm(Millipore). For filtration, ceramic Büchner funnels 
(Coorstek) and 500 ml filtration flasks (KIMAX) were used. For air drying and weighing 
the residues, 20 ml disposable scintillation vials were used.     
     Cells were grown in 40 ml or 400 ml culture flasks (Nunc).  Falcon tubes (15 ml and 50 
ml) (Fisher) were utilized for cell inoculation and centrifugation. Cytotoxicity and cell 
viability were tested in individual wells of flat bottom 96 well Cell Culture Clusters with 
lid (Costar). Testing for antioxidant activity was performed in individual wells of flat 
bottom 48 well Cell Culture Clusters with lid (Costar). Sterilization of the tested extracts 
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was done using sterile syringe filters of 0.2 µm pore-size, supplied by Nalgene, and 
sterile 10 ml syringes (Becton-Dickinson).  Cell counting was performed using a 
hemocytometer of 0.1 mm depth (Hausser Scientific).  
     For growing bacteria, 100 X 15 mm and 150 X 15 mm sterile polystyrene petri dishes 
and 30 mm cell spreaders were used (Fisher Scientific). In addition, disposable 16 X 100 
mm borosilicate glass culture tubes were used for broth dilution assay..   
3.3 Instrumentation and equipment 
     Extraction procedures and handling of solvents were done in a standard fume hood 
(Flores Valles). Homogenization and blending was accomplished using Polytron PT 10-35 
GT homogenizer(Kinematica). Stirring was accomplished using Super-Nuova stirring hot 
plates (Scientific). Evaporation of solvents was done using Rotavapor R-215 rotary 
evaporator(Buchi). Ultrasound homogenization and solubilization of extracts were done 
using Ultrasonic Homogenizer model 150 VT, (Biologics Inc.), and Bandelin Sonorex RK-
52 sonication bath (Sonorex). The extracts were stored in Revco Laboratory Refrigerator 
(Thermo scientific) at 4º C. Weighing was performed using Mettler Toledo Standard 
Interface Command Cell weighing balance. Digital Vortex Mixerwas used to vortex 
solutions in order to help solubilizing undissolved matter (Fisher Scientific).      
     Handling of cell lines and primary cells was done in Labguard Class II Biological Safety 
Cabinet (Biologics, Inc.). Cells were incubated in Series II Water Jacket Carbon Dioxide 
Incubator (Thermo scientific). Cell counting and viewing was performed using Eclipse 
TS100 microscope (Nikon). For warming purposes, Thermoscientific Precision Water 
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Bath model 183 was used. Centrifugation of plates and Falcon tubes was done using 
Sorvall ST 16R centrifuge (Thermoscientific). Fluorescence Activated Cell Sorting was 
performed using FACSCANTO II flow cytometer (BD). Spectrophotometric readings were 
taken using Bio-Rad xMark Microplate Spectrophotometer.  
     Autoclaving was performed using Raypa Steam Sterilizers (TradeRaypa). Fisher 
Scientific Isotemp Economy Lab Incubator was used for incubation of petri-dishes. 
Excella E24 Incubator Shaker was used to incubate and shake bacterial suspensions 
(New Brunswick Scientific). Pictures of petri-dishes were taken using Kodak Image 
Station 4000 MM.    
3.4 Extraction of plants   
     10 grams of each ( i.e. dried flowers and flowering tops of Matricaria chamomilla, the 
twigs of Salvadora persica and the leaves of Artemisia annua) were extracted using 200 
ml of absolute methanol. Polytron homogenizer was used to crush the plant material. 
The extraction was done for five days with continuous gentle stirring, in order to get the 
maximum yield. After that, extracts were sonicated for two hours using the ultrasound 
homogenizer, because sonication provides an efficient method for extracting tightly 
bound chemicals from solid surfaces such as plants [73]. To remove the remaining plant 
material and particulate matter, extracts were filtered in 500 ml filter flasks using 11 µm 
pore-sized filter papers. Following this filtration, extracts were filtered again in other 
500 ml filter flasks using 0.22 µm pore-sized membrane filters to reduce bacterial 
contamination of the extracts [74]. The concentration of each crude extract was 
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determined by drying and weighing. 1 ml of the extract was transferred to an empty 
weighed 20 ml vial. The extract was air dried and then the vial was re-weighed. 
3.5 Preparation of extracts 
     Extracts were prepared in different concentrations of dry residues in the appropriate 
solvents. This was done by calculating the volumes of the crude methanol extracts that 
could contain the desirable weights of the dry material (depending on the known 
concentrations of the extracts). For each concentration of one extract, the volume 
corresponding to the desired weight of dry residue was transferred to a round bottom 
flask and dried using the rotary evaporator. The dry residues were then dissolved in 
certain volumes of the appropriate solvents that would give the desired concentrations. 
These solutions were sonicated using the sonication bath to help dissolve any 
undissolved matter. To control bacterial contamination in anti-cancer assays, the 
prepared concentrations were filtered using syringe filters of 0.22 µm pore size.  
3.6 Screening for anti-cancer activity 
3.6.1 Preparation of growth media and cells  
     All cell handling took place in Lab Guard Class II Biological Safety Cabinet after it was 
exposed to UV light for at least 30 minutes. Six cell lines were purchased from the 
American Type Culture Corporation (ATCC): Human Breast Adenocarcinoma MCF7, 
Human Embryonic Kidney 293T/17, Human Lung Fibroblasts WI-38, Human Cervical 
Adenocarcinoma Hela, Human Lung Carcinoma HLF-a and Chinese Hamster Ovary CHO-
K1. These six cell lines were frozen in a cryogenic chamber. To prepare growth media, 50 
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ml of each 500 ml bottle of both DMEM and FGM were replaced by 50 ml of FBS, so that 
the final concentration of FBS in each bottle of growth media would be 10%. The 
following procedures were done to start a new culture from each type of frozen cell 
lines. Cells were thawed by rubbing the tubes with hands for a few minutes, suspended 
in DMEM, and centrifuged for 3 minutes. The supernatant was discarded and the pellet 
was re-suspended in 5 mL of fresh DMEM by pipetting. The cells were then transferred 
to 40 ml cell culture flasks and allowed to grow at 37º C in 5% Carbon dioxide 
atmosphere in the incubator for 3 to 6 days. After that, the DMEM was aspirated from 
the cell culture flask, and the cells were washed with 1X PBS and then released by 
incubation with 0.3 ml of trypsin for 5 to 15 minutes. 2 ml of DMEM were added to 
wash down all cells. Cells were split in 1:3 fashion. To the remaining 0.5 ml of cell 
suspension in the flask, 6 ml of DMEM were added and the flask was incubated at 37º C 
in 5% carbon dioxide atmosphere in the incubator to allow the cells to grow for other 
purposes. The other 1.5 ml of cell suspension were counted, diluted and added to 96 
well plates.  
     Two types of primary cells were obtained from Invitrogen: Primary Human Dermal 
Fibroblasts isolated from adult skin (aHDF) and Primary Human Dermal Fibroblasts 
isolated from neonatal foreskin (nHDF). The cells were cryopreserved. For each type, 
cells were thawed by rubbing the tubes with hands for a few minutes, suspended in 
Fibroblast Growth Medium (FGM) and centrifuged for 3 minutes. The supernatant was 
discarded and the pellet was re-suspended in 5 ml of fresh FGM by pipetting. The cells 
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were then counted, diluted, transferred to the 96 well plates directly and incubated for 
one day at 37 ºC in 5% carbon dioxide atmosphere in the incubator.   
3.6.2 Adjusting cell number 
     The total cell number in each ml of a cell suspension was calculated using the 
hemocytometer. 8 μL of each cell suspension were loaded at one side of the 
hemocytometer. The cells were counted under a microscope and the concentration of 
the cell suspension was calculated as follows:   
1. The average of the number of cells from the four quadrants was calculated. 
2. The average was multiplied by 2 X 104 to get the final concentration of cells/ml.  
3. C1V1 = C2V2 was used to determine the volume of cell suspension (V1) required to 
get the desired final concentration (C2).  
3.6.3 Cell viability assay (alamarBlue assay) 
     The cell count was adjusted to 104 cells/ml for each cell line. This was a suggested cell 
density which has worked in published studies with cancer cell lines [75]. 200μl of cell 
suspension of each cell line were added to six wells of a flat bottom 96 well plate with 
lid. The plate was incubated at 37°C in 5% CO2 atmosphere for 24 hours. After that, the 
growth media were aspirated from each well and solutions of tested extracts in growth 
media were added to the wells. In addition, two controls were included in the plate: 
70% DMSO in growth media (negative control) and growth medium(positive control). 
The plate was incubated for 48 hours at 37°C in 5% CO2 atmosphere. After incubation, 
200μl of the indicator (10% alamarBlue in growth media) were added to each well. The 
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plate was incubated for an additional 3 hours in at 37°C in 5% CO2 atmosphere. After 
that, the plate was read spectrophotometrically (absorbance at 570nm and 600nm 
wavelengths) using the microplate spectrophotometer. According to the reagent 
manual, the percentages of viable cells of each cell type in comparison with the 
corresponding positive growth controls were calculated using this equation: 
 (εOX) λ2 Aλ1 - (εOX) λ1 Aλ2 of test agent dilution 
 (εOX) λ2 A°λ1 - (εOX) λ1 A°λ2 of untreated control 
Where: 
εOX = molar extinction coefficient of alamarBlue oxidized form (BLUE). 
A = absorbance of test wells 
A° = absorbance of untreated control well 
λ1 = 570nm  
λ2 = 600nm 
The molar extinction coefficient of alamarBlue oxidized form at 570 nm wavelength is 
80586. 
The molar extinction coefficient of alamarBlue oxidized form at 600 nm wavelength is 
117216. 
3.6.4 The LIVE/DEAD Viability/Cytotoxicity Assay 
     Using the hemocytometer, the cell count was adjusted to 1,700,000 cells/ml for each 
cell type as recommended by the kit manual. 200μl of the cell suspension of each cell 
type were added to six wells of a flat bottom 96 well plate with lid. The plate was 
incubated at 37°C in 5% CO2 atmosphere for 24 hours. After that, the growth media 
X 100 
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were aspirated from all wells and different concentrations of the tested extracts in 
growth media were added to the wells. In addition, two controls were included in the 
plate, a positive control and a negative control. The positive killing control was done by 
adding 70% DMSO in growth media to cell containing wells. The negative killing control 
was done by just adding growth media to cell containing wells. The plate was incubated 
for 48 hours at 37°C in 5% CO2 atmosphere. After that, all the growth media inside these 
wells were transferred into falcon tubes that were labeled correspondingly. The cells 
that remained attached to the bottoms of the wells were trypsinized, re-suspended in 
growth media and transferred to the corresponding Falcon tubes.  
     Different from treatment controls, staining controls were done to make sure that the 
stains work properly. Three staining controls were made for each cell line: one 
representing dead cells, one representing live cells and one representing live cells 
without staining. To make the controls representing the dead cells, untreated cells from 
each cell type growing in 40 ml culture flasks were trypsinized and the cell density was 
adjusted to the previously mentioned cell density using the hemocytometer. Then, cell 
suspensions were transferred into Falcon tubes. The tubes were centrifuged for 3 
minutes at 1400 revolutions per minute (rpm). Growth media were aspirated and the 
pellets were incubated in 70% methanol at room temperature for 30 minutes. After 
that, cell suspensions in 70% methanol were centrifuged at 1400 rpm for 3 minutes and 
methanol was aspirated. The pellets were re-suspended in growth media. To make the 
controls representing live cells that were later stained or left unstained, untreated cells 
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from each type growing in 40 ml culture flasks were trypsinized and the cell densities 
were adjusted to the previously mentioned value using the hemocytometer. Then, cell 
suspensions were transferred into Falcon tubes and left as they are.       
     80-fold dilution of calcein AM (component A of the kit) in DMSO was made by adding 
2 µl of calcein AM to 158 µl of DMSO. This solution was labeled as calcein AM working 
solution. For each ml of a cell suspension, 2 μl of calcein AM working solution and 4 μl of 
the 2 mM ethidium homodimer-1 stock (component B of the kit) were added. For each 
cell line, the treated cells, the negative control (untreated) and the positive control (70% 
DMSO treated cells) were stained with both dyes in the previously mentioned manner. 
In addition, staining controls were stained as follows: dead cells (methanol treated cells) 
were stained only with 2 mM ethidium homodimer-1 stock, live cells were stained only 
with calcein AM working solution, and other live cells were left unstained. The stained 
suspensions were mixed gently and incubated for 20 minutes in darkness at room 
temperature. After that, all the tubes were analyzed by the flow cytometer using 488 
nm excitation and measuring green fluorescence emission for calcein (i.e., 530/30 
bandpass) and red fluorescence emission for ethidium homodimer-1 (i.e., 610/20 
bandpass).   
 
3.6.5 LDH Cytotoxicity Detection Assay 
      Using the hemocytometer, the cell count was adjusted to 105 cells/ml for each cell 
type as recommended by the kit manual. 200 μl of cell suspension of each cell line were 
added to six wells of a flat bottom 96 well plate with lid. The plate was incubated at 
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37°C in 5% CO2 atmosphere for 24 hours. After that, the growth media were aspirated 
from all wells and different concentrations of the tested extracts in growth media were 
added to the wells. In addition, two controls were included in the plate, a positive killing 
control and a negative killing control. The positive control was done by adding 1% Triton 
X-100 in growth medium to cell containing wells. The negative control was done by just 
adding growth medium to cell containing wells. The plate was incubated for 48 hours at 
37°C in 5% CO2 atmosphere. The reaction mixture was prepared by mixing 250 μl of 
solution A (catalyst) with 11.25 ml of solution B (dye solution). 
     After that, the plate was centrifuged at 250Xg for 10 minutes. Then, 100 μl of the 
supernatant in each well was removed carefully, without disrupting the pellet, and 
transferred into a corresponding well of another 96-well flat bottom microtiter plate. To 
each well in the second plate, 100 μl of the reaction mixture were added. The plate was 
incubated away from light at room temperature for 30 minutes. After that, the 
absorbance of the samples was measured at a wavelength of 492 nm. Percentage of 
cytotoxicity was calculated using the following equation: 
Absorbance in wells of tested substances – absorbance of negative control 
     Absorbance of positive control – absorbance of negative control 
3.7 Screening for anti-bacterial activity 
3.7.1 Preparation of bacterial cultures 
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     GC5 competent Escherichia coli cells were purchased from Sigma-Aldrich and stored 
in -80º C Revco freezer. 40 grams of Luria Agar were dissolved in 1 liter of distilled water 
and sterilized in the autoclave by steam heating at 121º C for 20 minutes. The sterile 
agar solution was poured into 100 x 15 mm and 150 x 15 mm sterile polystyrene petri 
dishes in Lab Guard Class II Biological Safety Cabinet to prevent contamination. The petri 
dishes were left to cool down and to allow the agar solution to solidify. Excess agar 
plates were stored at 4º C in Revco refrigerator. Others were thawed at 37º C in 
Scientific Isotemp Economy Lab Incubator.  
      25 grams of Difco LB Broth were dissolved in 1 liter of distilled water and sterilized in 
the autoclave by steam heating at 121º C for 20 minutes. Excess amounts of LB Broth 
were stored at 4º C in Revco refrigerator. A vial containing GC5 competent Escherichia 
coli cells was thawed by rubbing with hands, and then 1 ml of LB Broth was added to the 
vial. The cell pellet was re-suspended by pipetting in the LB Broth. Then, that 1ml of LB 
Broth, containing GC5 competent Escherichia coli cells, was applied to an agar plate. It 
was spread properly over the agar surface using a cell spreader. The covered plate was 
incubated for 24 hours in an inverted position at 37º C in Scientific Isotemp Economy 
Lab Incubator.  
3.7.2 Disk Diffusion assay 
     Disks were obtained from grade 1 11 µm pore-sized filter papers (Whatman) using a 
paper puncher. Then, disks were exposed to UV radiation in Class II Biological Safety 
Cabinet for sterilization. After that, the disks were soaked in different concentrations of 
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solutions of tested materials, in 8% DMSO in water, and controls for 12 hours. 8% DMSO 
in water was chosen as a solvent, because higher concentrations of DMSO have 
antibacterial activity against Escherichia coli [76]. In addition, 100 mg/ml ampicillin 
solution in distilled water and 50 mg/ml kanamycin solution in distilled water were 
prepared and disks were soaked in them to serve as positive controls. Also, some disks 
were soaked in the solvent of the tested materials (8% DMSO) to serve as negative 
controls. The inoculum was prepared by suspending isolated colonies from the 
overnight incubated agar plate in LB Broth to a turbidity matching 0.5 McFarland 
standard [77]. Then, the inoculum was applied to new room temperature agar plates 
and spread properly using a cell spreader. Disks that were soaked in the solutions of 
tested materials and the controls were applied manually to the agar plates using 
tweezers. The plates were left for 30 minutes to dry. Then, they were covered and 
incubated for 24 hours in an inverted position at 37º C in Isotemp Economy Lab 
Incubator. Following the incubation process, images of the plates were taken using 
KODAK Image Station 4000 MM. The lengths of zones of inhibition were measured using 
a ruler.     
3.7.3 Macrobroth Dilution assay 
      Eleven test tubes were plugged with cotton and sterilized in the autoclave by moist 
heating at 121º C for 20 minutes.  They were labeled 1 through 10. 0.5 ml of LB Broth 
was pipetted into tubes 1–10. 0.5 ml of the tested solution was pipetted into tube 1. 0.5 
ml was pipetted from the mixture in tube 1 to tube 2 and continued through tube 8. 
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Changing pipette tips between tubes was necessary to prevent carryover of the tested 
solution. 0.5 ml was discarded from tube 8. The ninth tube, which is a control, received 
no extract. The tenth tube contained only LB Broth. The eleventh tube 4–5 isolated 
colonies from an overnight culture were selected and diluted in LB Broth to a turbidity 
matching 0.5 McFarland turbidity standard (approximately 108 CFU/mL). This 
suspension was further diluted 1:100 (106 CFU/mL) with LB Broth [78]. Within 15 min of 
the preparation of this inoculum, 0.5 ml of the inoculum was added to each tube except 
the eleventh (last) tube, which is the broth control tube. The final inoculum 
concentration of 105 CFU/mL was achieved by that time. The final concentration of the 
tested solution was half of the original concentration in each tube by that time. The 
tubes were incubated and shaken gently for 24 hours at 37º C using Excella E24 
Incubator Shaker. To determine the Minimal Bactericidal Concentration (MBC) of the 
tested solution, 50 µl were pipetted out of each tube following the incubation period 
and spread onto a new thawed agar plate labeled with the same number of the tube. 
The plates were incubated for 24 hours at 37º C in Isotemp Economy Lab Incubator. 
After the incubation period was passed, the number of colonies in each plate was 
counted. The number of colonies corresponding to a thousand-fold reduction (as 
compared to the colony count of the start inoculum) was recorded as the MBC (99.9% 
killing) [78].  
3.8 Screening for antioxidant activity 
1, 1-diphenyl-2-picryl-hydrazyl (DPPH) assay 
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     The tested extracts were prepared in different concentrations of dry residues in 
absolute ethanol. DPPH particles were dissolved in absolute ethanol to give a 
concentration of 1 mM [79]. To each well of a 48-well microtiter plate, 500 µl of the 
tested solutions and 125 µl of DPPH in ethanol were added and mixed gently. A 
concentration of 50 µg/ml of ascorbic acid in ethanol was used as a positive control [79]. 
Negative control wells contained 500 µl of absolute ethanol and 125 µl of DPPH in 
ethanol. The plate was covered and incubated at 37 degree C for 30 minutes in Isotemp 
Economy Lab Incubator. After that, the absorbance in each well was measured at a 
wavelength of 517 nm using the spectrophotometric microtiter plate reader. The free 
radical scavenging activity was calculated using the following equation[79]: 
Scavenging effect (%) =    
Where A0 was the absorbance of the negative control reaction and A1 was the 
absorbance in the presence of the sample of the tested extracts. 
 
 
 
 
 
 
X 100 
A0  
A0 − A1 
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Chapter 4 
Results and Discussion 
4.1.1 Cytotoxicity of Matricaria chamomilla 
     Using the extraction procedures previously mentioned in Chapter 3, the methanolic 
extract of Matricaria chamomilla had a concentration of 11.6 mg/ml. Two different 
concentrations of the dry residue of the extract in DMEM were prepared, in order to 
test for the effect of the extract on cell lines: 20 µg/ml and 50 µg/ml. Three cell lines 
were used in this experiment: Hela, Human Breast Adenocarcinoma and Human 
Embryonic Kidney. After incubating the microtiter plates that contained treated and 
non-treated cells, the stains of the LIVE/DEAD Viability/Cytotoxicity Kit were added to 
the wells of the microtiter plate that contained those microscopically examined cells, 
the cells were analyzed using the flow cytometer as described in Chapter 3. Figures 22, 
23 and 24 show the results of flow cytometric analysis of extract treated cells, 70% 
DMSO treated cells and untreated cells after 48 hours of incubation of Hela, Human 
Breast Adenocarcinoma and Human Embryonic Kidney respectively.    
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Figure 22.Flow cytometric analysis of cytotoxicity and viability measurements of Hela 
cells after 48 hour incubation, using The LIVE/DEAD Viability/Cytotoxicity assay. The 
analysis was carried out with an excitation of 488 nm. In each figure, the vertical axis 
represents the green fluorescence emission (calcein AM) and the horizontal axis 
represents the red fluorescence emission (ethidium homodimer). In each figure, the 
area Q1 represents viable cells stained with calcein AM, the area Q4 represents dead 
cells stained with ethidium homodimer, the area Q3 represents the cells which are not 
stained at all, and the area Q2 represents the cells stained with both stains. Figure (A) 
represents unstained live cells that were used as a control, (B) live cells stained with 
calcein AM only (staining control), (C) methanol treated dead cells stained with EthD-1 
only (staining control), (D) untreated cells stained with both stains, (E) 70% DMSO in 
DMEM treated cells stained with both stains, (F) 20 µg/ml of Matricaria chamomilla 
extract in DMEM treated cells stained with both stains and (G) 50 µg/ml of Matricaria 
chamomilla extract in DMEM treated cells stained with both stains. This is a 
representative experiment of 2 experiments (n=2). 
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Figure 23. Flow cytometric analysis of cytotoxicity and viability measurements of Breast 
Adenocarcinoma cells after 48 hour incubation, using The LIVE/DEAD 
Viability/Cytotoxicity assay. The analysis was carried out with an excitation of 488 nm. In 
each figure, the vertical axis represents the green fluorescence emission (calcein AM) 
and the horizontal axis represents the red fluorescence emission (ethidium homodimer). 
In each figure, the area Q1 represents viable cells stained with calcein AM, the area Q4 
represents dead cells stained with ethidium homodimer, the area Q3 represents the 
cells which are not stained at all, and the area Q2 represents the cells stained with both 
stains. Figure (A) represents unstained live cells that were used as a control, (B) live cells 
stained with calcein AM only (staining control), (C) methanol treated dead cells stained 
with EthD-1 only (staining control), (D) untreated cells stained with both stains, (E) 70% 
DMSO in DMEM treated cells stained with both stains, (F) 20 µg/ml of Matricaria 
chamomilla extract in DMEM treated cells stained with both stains and (G) 50 µg/ml of 
Matricaria chamomilla extract in DMEM treated cells stained with both stains. This is a 
representative experiment of 2 experiments (n=2). 
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Figure 24. Flow cytometric analysis of cytotoxicity and viability measurements of Human 
Embryonic Kidney cells after 48 hour incubation, using The LIVE/DEAD 
Viability/Cytotoxicity assay. The analysis was carried out with an excitation of 488 nm. In 
each figure, the vertical axis represents the green fluorescence emission (calcein AM) 
and the horizontal axis represents the red fluorescence emission (ethidium homodimer). 
In each figure, the area Q1 represents viable cells stained with calcein AM, the area Q4 
represents dead cells stained with ethidium homodimer, the area Q3 represents the 
cells which are not stained at all, and the area Q2 represents the cells stained with both 
stains. Figure (A) represents unstained live cells that were used as a control, (B) live cells 
stained with calcein AM only (staining control), (C) methanol treated dead cells stained 
with EthD-1 only (staining control), (D) untreated cells stained with both stains, (E) 70% 
DMSO in DMEM treated cells stained with both stains, (F) 20 µg/ml of Matricaria 
chamomilla extract in DMEM treated cells stained with both stains and (G) 50 µg/ml of 
Matricaria chamomilla extract in DMEM treated cells stained with both stains. This is a 
representative experiment of 2 experiments (n=2). 
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     As shown in Figures 22 (A), 23 (A) and 24 (A), unstained cells usually appear in Q3 
areas. According to Figures 22 (B), 23 (B) and 24 (B) which represent live cells stained 
with calcein AM only, live cells appear in Q1 areas of the charts. Figures 22 (C), 26 (C) 
and 27 (C) show that dead cells appear in Q4 areas of charts. Q2 areas represent cells 
which were double stained with calcein AM and EthD-1 at the same time, suggesting 
that these cells were on their ways to death, or that these cells suffered from some 
signs of cell death but they were not left for enough time till complete death. As shown 
in Figures 22 (E), 23 (E) and 24 (E), most of cells treated with 70% DMSO in DMEM were 
double stained, suggesting that they had to be left for a longer incubation period to 
show more cytotoxicity. It is surprising that Figure 22 (F) shows that 20 µg/ml treated 
Hela cells have higher percentage of viability than the untreated ones, while 50 µg/ml 
treated Hela cells did not show much difference from untreated ones. In Figure 23 (F), 
20 µg/ml treated Human Breast Adenocarcinoma cells are shown to have slightly more 
cell death than the untreated ones, while Figure 23 (G) shows that 50 µg/ml treated 
cells were surprisingly more viable than the control itself. Figures 24 (F) and (G) show 
that 20 µg/ml and 50 µg/ml treated Human Embryonic Kidney cells are not much 
different from the untreated ones. This experiment was repeated (n=2) and similar 
results were obtained. Unfortunately, the results of this experiment are not precise and 
some of them, such as the ones shown in Figure 22 (F) and Figure 23 (G) do not make 
sense.  
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     In order to have more precise results that can be expressed in numbers and 
percentages, the alamarBlue assay was used to detect the percentage of cell viability of 
treated cells. In addition to the three previously mentioned cell lines, Human Lung 
Fibroblasts were used. Due to the possibility that crude extracts can have bioactive 
molecules in very low concentrations, it was decided that higher concentrations of the 
extract in DMEM would be used, such as 100 µg/ml and 200 µg/ml. The four cell lines 
were treated with these two concentrations and compared to positive growth controls 
(untreated cells) and 70% DMSO in DMEM treated controls. Absorbance readings were 
taken after 3 hours and 6 hours of incubation of the cells with the indicator. The 
percentage of cell viability was calculated as described in Chapter 3. Figures 25, 26, 27 
and 28 show the percentages of viability of Hela cells, Human Breast Adenocarcinoma 
cells, Human Embryonic Kidney cells and Human Lung Fibroblasts in this experiment.  
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Figure.25 Percentages of cell viability of Hela cells treated with Matricaria chamomilla 
extract after 3 hours and 6 hours of incubation using the alamarBlue reagent. The 
vertical axis represents the percentage of viable cells. The horizontal axis represents the 
controls and the concentrations of the extract used in the experiment. DMSO is used as 
a positive control that has potent cytotoxic effect and untreated cells are used as a 
negative control. This is a representative experiment of 2 experiments (n=2).  
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Figure.26 Percentages of cell viability of Human Breast Adenocarcinoma cells treated 
with Matricaria chamomilla extract after 3 hours and 6 hours of incubation using the 
alamarBlue reagent. The vertical axis represents the percentage of viable cells. The 
horizontal axis represents the controls and the concentrations of the extract used in the 
experiment. DMSO is used as a positive control that has potent cytotoxic effect and 
untreated cells are used as a negative control. This is a representative experiment of 2 
experiments (n=2).  
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Figure 27.Percentages of cell viability of Human Embryonic Kidney cells treated with 
Matricaria chamomilla extract after 3 hours and 6 hours of incubation using the 
alamarBlue reagent. The vertical axis represents the percentage of viable cells. The 
horizontal axis represents the controls and the concentrations of the extract used in the 
experiment. DMSO is used as a positive control that has potent cytotoxic effect and 
untreated cells are used as a negative control. This is a representative experiment of 2 
experiments (n=2).  
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Figure 28.Percentages of cell viability of Human Lung Fibroblasts treated with Matricaria 
chamomilla extract after 3 hours and 6 hours of incubation with the alamarBlue 
reagent. The vertical axis represents the percentage of viable cells. The horizontal axis 
represents the controls and the concentrations of the extract used in the experiment. 
DMSO is used as a positive control that has potent cytotoxic effect, and untreated cells 
are used as a negative control. This is a representative experiment of 2 experiments 
(n=2).  
     From the results shows in Figures 25, 26, 27 and 28, it was confirmed for the second 
time that 70% DMSO in DMEM had a potent cytotoxic effect that suggested the use of it 
as a positive cell killing control in all other experiments. It was clear that the extract of 
Matricaria chamomilla had no significant cytotoxic activity against all the cell lines used 
in this experiment, even in a concentration of 200 µg/ml. The lowest cell viability 
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achieved by the extract was 75% in case of Human Breast Adenocarcinoma cells treated 
with 100 µg/ml. It is clear that this cell line is the most sensitive one to the extract in 
terms of cytotoxicity. On the other hand, Human Embryonic Kidney cells and Human 
Lung Fibroblasts that were treated with both concentrations of the extract showed an 
elevation in the percentages of cell viability, suggesting that the extract potentiates cell 
viability rather than promoting cell death, as shown in Figures 27 and 28. This 
experiment was repeated (n=2) and similar results were obtained. The same 
concentrations of the extract in (FGM) were tested for cytotoxicity against adult and 
neonatal Human Dermal Fibroblasts using the LDH Cytotoxicity Detection kit as 
described in Chapter 3. The results are shown in Figure 29, where they are plotted as 
percent cytotoxicity rather than percent viability as in previous figures. This experiment 
was repeated (n=2) and similar results were obtained. It was confirmed from the results 
that the extract of Matricaria chamomilla had no cytotoxic activity against the used 
primary cells.  
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Figure 29.Percentages of cytotoxicity of chamomile extract against adult and neonatal 
Human Dermal Fibroblasts using the LDH Cytotoxicity Detection Kit. The vertical axis 
represents the cytotoxicity percentages. The horizontal axis represents the controls and 
the concentrations of the extract used in the experiment. Triton is used as a positive 
control that has high cytotoxic potential and untreated cells are used as a negative 
control. This is a representative experiment of 2 experiments (n=2).  
 
4.1.2 Antibacterial activity of Matricaria chamomilla 
     Disk diffusion assay was performed to test for the antibacterial effect of Matricaria 
chamomilla extract against Escherichia coli as described in Chapter 3. A solution of 300 
mg/ml of dry residue extract in 8% DMSO was prepared. Figure 30 shows the images of 
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the agar plate used in this experiment that were taken after 24 hours, 48 hours and 72 
hours of incubation.  
 
Figure 30.Disk diffusion assay for 300 mg/ml of Matricaria chamomilla extract in 8% 
DMSO. The images were taken after: (A) 24 hour incubation, (B) 48 hour incubation and 
(C) 72 hour incubation. In each picture, the upper disc serves as a positive control 
(ampicillin). The lower left disc serves as a vehicle control (8% DMSO) and the lower 
right disc contains the extract. This is a representative experiment of 2 experiments 
(n=2). 
     As shown in Figure 30, the extract of chamomile at a concentration of 300 mg/ml in 
8% DMSO had a significant persistent antibacterial activity against Escherichia coli. The 
activity persisted for 3 days without any changes. The inhibition zone around the disk 
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that had been soaked in the extract (the right disk) was 1.7 cm in length, while the 
inhibition zone of the disk soaked in ampicillin 100 mg/ml (the upper disk) was 4 cm in 
length. The solvent (8% DMSO) did not show significant antibacterial activity. In addition 
to the clear inhibition zone around the disk soaked in the extract, there was a zone 
where slight growth of the microorganism is noticed. These results suggested that the 
crude extract of Matricaria chamomilla possesses antibacterial activity against 
Escherichia coli. This experiment was repeated (n=2) and similar results were obtained. 
To determine the lowest concentration of the extract required to generate an 
antibacterial effect, Macrobroth Dilution assay was performed as described in chapter 3. 
The starting concentration of the extract, which was added to tube number 1, was 200 
mg/ml in 8% DMSO. After the addition of LB Broth, the concentration in tube 1, which 
was the highest concentration used in this experiment, became 100 mg/ml. Tubes 1-8 
contained serial dilutions of the extract as described in Table 1. 
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Tube Number Content 
1 100 mg/ml of the extract in 8% DMSO 
2 50 mg/ml of the extract in 8% DMSO 
3 25 mg/ml of the extract in 8% DMSO 
4 12.5 mg/ml of the extract in 8% DMSO 
5 6.25 mg/ml of the extract in 8% DMSO 
6 3.125 mg/ml of the extract in 8% DMSO 
7 1.563 mg/ml of the extract in 8% DMSO 
8 0.781 mg/ml of the extract in 8% DMSO 
9 No extract (control) 
10 No extract, no bacteria (broth control) 
Table 1.The contents of each tube in the Macrobroth Dilution assay designed to test for 
the MBC of the extract of chamomile. 
    As described in Chapter 3, the tubes were incubated at 37° C for 24 hours, and then a 
sample from each tube was streaked onto an agar plate numbered correspondingly. 
After incubating the plates at 37° C for 24 hours, images were taken. Figure 31 shows 
the images of all the 10 plates. 
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Figure 31.Agar plates on which the contents of the 10 tubes of the Macrobroth Dilution 
assay were streaked for evaluation of the antibacterial effect of chamomile. Each 
picture has the same number of the corresponding tube (see Table 1). This is a 
representative experiment of 2 experiments (n=2). 
     As shown in figure 31, plates 1 and 2 containing 100 mg/ml and 50 mg/ml of the 
extract in 8% DMSO respectively had no bacterial growth at all. They look very similar to 
plate 10, which had no bacteria added. Plate 3 that contained 25 mg/ml of the tested 
extract in 8% DMSO showed significant bacterial growth similar to that growth in plate 
9, the control plate that had no extract added. All the other concentrations represented 
in plates 4-8 had no antibacterial effect at all. These results suggested that 50 mg/ml of 
the chamomile extract in 8% DMSO is the lowest concentration that has significant 
antibacterial activity against Escherichia coli. This experiment was repeated (n=2) and 
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similar results were obtained. The crude extract of Matricaria chamomilla is thought to 
contain many compounds, like most plant crude extracts, which suggests that the active 
principle responsible for the antibacterial effect is found in a relatively high 
concentration in the crude extract. 
4.1.3 Radical scavenging activity of Matricaria chamomilla 
     The test for radical scavenging activity was performed using DPPH particles dissolved 
in ethanol as described in Chapter 3. A concentration of 2 mg/ml of the extract of the 
plant in absolute ethanol was tested for free radical scavenging activity. A concentration 
of 50 µg/ml of ascorbic acid in absolute ethanol was used as a positive control. Figure 32 
shows the results of this experiment in terms of radical scavenging activity. As shown in 
the Figure, the extract of Matricaria chamomilla showed significant free radical 
scavenging activity against the used DPPH particles. In terms of percentage, chamomile 
extract achieved 87% of scavenging activity, just 5% lower than 50 µg/ml of ascorbic 
acid, which is a well-known potent antioxidant [80, 81]. This experiment was repeated 
(n=2) and similar results were obtained. This result might explain why the extract of 
chamomile increased the viability of cell lines as previously shown in Figures 25, 26, 27 
and 31. It may be concluded that the extract of chamomile protects the cells from being 
damaged by oxidants, and in that way the viability of chamomile cells increases above 
the untreated controls. 
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Figure 32.Free radical scavenging activity of 2 mg/ml of extract of Matricaria 
chamomilla in absolute ethanol using DPPH particles. The vertical axis represents 
the free radical scavenging percentage and the horizontal axis represents the 
extracts and controls used. Ascorbic acid is used as a positive control, due to its 
high free radical scavenging activity. Untreated particles are used as a negative 
control. This experiment is representative of two experiments (n=2).  
4.1.4 Column fractionation of the extract of Matricaria chamomilla 
     In order to detect the source of the significant antibacterial and radical scavenging 
activities of the extract of Matricaria chamomilla, column chromatography was used. To 
divide the methanolic extract of the plant into several fractions, the glass fractionation 
column was packed with flash chromatography grade silica, having mesh size of 70 – 
230. 5 grams of the dry extract of Matricaria chamomilla were added to the column on 
top of the silica pack. A cotton plug was added above the dry extract in the column to 
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stabilize it. These four solvents were used as mobile phases: hexane, dichloromethane, 
ethyl acetate and methanol. 225 ml of hexane were added to the column and allowed to 
elute by gravity. After complete elution of the hexane fraction, 225 ml of 
dichloromethane were added to the column and allowed to elute by gravity. Following 
the elution of the dichloromethane fraction, the same step was repeated with 225 ml of 
each of ethyl acetate and methanol respectively. Each solvent fraction was obtained 
individually. The initial concentrations of the eluted fractions were 2 mg/ml for the 
hexane fraction, 7.5 mg/ml for the dichloromethane fraction, 1.5 mg/ml for the ethyl 
acetate fraction and 8.4 mg/ml for the methanol fraction. Each solvent fraction was re-
screened for antibacterial and radical scavenging activity using the same procedures 
described in Chapter 3. 
 
4.1.5 Antibacterial activities of the fractions of Matricaria chamomilla 
     Disk diffusion assay was performed to test for the antibacterial effect of the solvent 
fractions of Matricaria chamomilla extract against Escherichia coli as described in 
chapter 3. A concentration of 300 mg/ml of the dry residue of each fraction of the 
extract in 8% DMSO was prepared. Figures 33, 34, 35 and 36 show the antibacterial 
activities of the hexane fraction, dichloromethane fraction, ethyl acetate fraction and 
methanol fraction after 24 hours, 48 hours and 72 hours of incubation. 
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Figure 33.Disk diffusion assay for 300 mg/ml of hexane fraction of Matricaria 
chamomilla extract in 8% DMSO. The images were taken after: (A) 24 hour incubation, 
(B) 48 hour incubation and (C) 72 hour incubation. In each picture, the upper disc serves 
as a control (ampicillin). The lower right disc serves as a vehicle control (8% DMSO) and 
the lower left disc contains the extract. This is a representative experiment of 2 
experiments (n=2). 
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Figure 34.Disk diffusion assay for 300 mg/ml of dichloromethane fraction of Matricaria 
chamomilla extract in 8% DMSO. The images were taken after: (A) 24 hour incubation, 
(B) 48 hour incubation and (C) 72 hour incubation. In each picture, the upper disc serves 
as a control (ampicillin). The lower right disc serves as a vehicle control (8% DMSO) and 
the lower left disc contains the extract. This is a representative experiment of 2 
experiments (n=2). 
 
87 
 
 
Figure 35.Disk diffusion assay for 300 mg/ml of ethyl acetate fraction of Matricaria 
chamomilla extract in 8% DMSO. The images were taken after: (A) 24 hour incubation, 
(B) 48 hour incubation and (C) 72 hour incubation. In each picture, the upper disc serves 
as a control (ampicillin). The lower right disc serves as a vehicle control (8% DMSO) and 
the lower left disc contains the extract. This is a representative experiment of 2 
experiments (n=2). 
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Figure 36.Disk diffusion assay for 300 mg/ml of methanol fraction of Matricaria 
chamomilla extract in 8% DMSO. The images were taken after: (A) 24 hour incubation, 
(B) 48 hour incubation and (C) 72 hour incubation. In each picture, the upper disc serves 
as a control (ampicillin). The lower right disc serves as a vehicle control (8% DMSO) and 
the lower left disc contains the extract. This is a representative experiment of 2 
experiments (n=2). 
 
     As shown in Figures 30, 33, 34, 35 and 36, the antibacterial activity of the crude 
methanolic extract of Matricaria chamomilla against Escherichia coli was stronger and 
more significant than the activity of any individual fraction obtained from the extract. 
Each of these experiments was repeated (n=2) and the same results were obtained. 
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These results suggest that the antibacterial activity of that plant extract against 
Escherichia coli is not caused by a single compound. Instead, it might be caused by 
several molecules that have different polarities, which are obtained in different solvent 
fractions using column chromatography. Regarding the antibacterial activity of each 
individual solvent fraction, it is clear that the hexane and dichloromethane fractions are 
the most potent fractions, suggesting that most of the compounds that are responsible 
for the antibacterial activity against Escherichia coli are not highly polar.      
4.1.6 Radical scavenging activities of the fractions of Matricaria chamomilla 
     The test for radical scavenging activity was performed using DPPH particles dissolved 
in ethanol as described in Chapter 3. A concentration of 2 mg/ml of each solvent 
fraction of the crude extract in absolute ethanol was tested for free radical scavenging 
activity. A concentration of 50 µg/ml of ascorbic acid in absolute ethanol was used as a 
positive control. Figure 37 shows the results of this experiment in terms of radical 
scavenging activity. 
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Figure 37.Free radical scavenging activity of 2 mg/ml of each solvent fraction obtained 
from the crude extract of Matricaria chamomilla in absolute ethanol using DPPH 
particles. The fractions obtained were hexane fraction, dichloromethane 
fraction, ethyl acetate fraction and methanol fraction, represented by the 
horizontal axis. In the same experiment, the crude extract of chamomile was 
used. The vertical axis represents the free radical scavenging activity 
percentages. Ascorbic acid is used as a positive control, due to its high free 
radical scavenging activity. Untreated particles are used as a negative control as 
they lack any free radical scavenging activity. This is a representative experiment 
of 2 experiments (n=2). 
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     As seen in Figure 37, only the hexane fraction and the methanol fraction showed free 
radical scavenging activity. This experiment was repeated (n=2) and similar results were 
obtained. These results suggest that the compounds that are responsible for that 
activity are of diverse polarities. Some are highly polar, which are soluble in methanol, 
and some are non-polar, which are the ones soluble in hexane. Further investigation is 
required to isolate these compounds.   
4.2.1 Cytotoxic activity of Salvadora persica 
     Using extraction procedures previously mentioned in Chapter 3, the methanolic 
extract of Salvadora persica had a concentration of 2.6 mg/ml. Using the LDH 
Cytotoxicity Detection Kit, two concentrations of the dry residue of miswak extract in 
Fibroblasts Growth Medium (FGM) were tested for cytotoxic activity against aHDF and 
nHDF. The concentrations used were 100 µg/ml and 200 µg/ml. The experiment was 
performed as described in Chapter 3. The results in Figure 38 show the percentage of 
cytotoxicity of each concentration against primary cells.  
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Figure 38.Percentages of cytotoxicity of Salvadora persica extract against adult and 
neonatal Human Dermal Fibroblasts using the LDH Cytotoxicity Detection Kit. The 
horizontal axis represents the used samples and controls. The vertical axis represents 
the percentages of cytotoxicity. Triton is used as a positive control, because it has a 
potent cytotoxic activity. Untreated cells are used as a negative control. This is a 
representative experiment of two experiments (n=2). 
     It is clear from Figure 38 that the extract of miswak had no significant cytotoxic 
activity against the used neonatal Human Dermal Fibroblasts. The extract achieved a bit 
higher cytotoxicity against adult Human Dermal Fibroblasts. However, 14% of 
cytotoxicity cannot be considered as a significant result. To see the effect of miswak 
extract on other cell lines, a concentration of 200 µg/ml of miswak extract in DMEM was 
tested for cytotoxicity using the LDH Cytotoxicity Detection Kit against Human Lung 
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Fibroblasts, Human Embryonic Kidney, Hela and Human Breast Adenocarcinoma cell 
lines. Figure 39 shows the percentages of cytotoxicity of these cells in this experiment.  
Figure 39.Percentages of cytotoxicity of miswak extract against Human Lung fibroblasts, 
Human Embryonic Kidney, Hela and Human Breast Adenocarcinoma cell lines using the 
LDH Cytotoxicity Detection Kit. The horizontal axis represents the used samples and 
controls. The vertical axis represents the percentages of cytotoxicity. Triton is used as a 
positive control, because it has a potent cytotoxic activity. Untreated cells are used as a 
negative control. This is a representative experiment of two experiments (n=2). 
     Results shown in Figure 39 suggest that the extract of Salvadora persica does not 
have significant cytotoxic effect against the four cell lines used: Human Lung fibroblasts, 
Human Embryonic Kidney, Hela and Human Breast Adenocarcinoma. Each of these 
experiments was repeated (n=2) and similar results were obtained.   
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4.2.2 Antibacterial activity of Salvadora persica 
     Disk Diffusion assay was performed to see if 300 mg/ml of miswak extract in 8% 
DMSO had any antibacterial activity against Escherichia coli. The agar plate was imaged 
after 24 hours, 48 hours and 72 hours of incubation. Figure 40 shows the results of the 
Disk Diffusion assay. 
Figure 40.Disk diffusion assay for 300 mg/ml of miswak extract in 8% DMSO. The images 
were taken after: (A) 24 hour incubation, (B) 48 hour incubation and (C) 72 hour 
incubation. In each picture, the upper disc serves as a control (ampicillin). The lower 
right disk serves as a vehicle control (8% DMSO) and the lower left disk contains the 
extract. This is a representative experiment of two experiments (n=2). 
      Figure 40 shows that there was no significant antibacterial activity of 300 mg/ml of 
Salvadora persica extract against Escherichia coli. This experiment was repeated (n=2) 
and similar results were obtained. As previously mentioned in chapter 2, the extract of 
Salvadora persica possesses antibacterial activity against several genera of bacteria, 
which are Staphylococcus aureus, Streptococcus mutans, Strep. faecalis, Strep. pyogenis, 
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Lactobacillus acidophilus, Pseudomonas aeruginosa, and Candida albicans [60]. 
However, it lacks this activity against Escherichia coli. This observation suggests that the 
antibacterial activity against other bacterial species is mediated through different 
molecules and different mechanisms of actions that may not affect Escherichia coli. 
4.2.3 Free radical scavenging activity of Salvadora persica 
     The test for radical scavenging activity was performed using DPPH particles dissolved 
in ethanol as described in Chapter 3. A concentration of 2 mg/ml of the extract of the 
plant in absolute ethanol was tested for free radical scavenging activity. A concentration 
of 50 µg/ml of ascorbic acid in absolute ethanol was used as a positive control. Figure 41 
shows the results of this experiment in terms of radical scavenging activity. As shown in 
the figure, the extract of Salvadora persica showed only 12% of free radical scavenging 
activity, which cannot be considered as a significant activity. This experiment was 
repeated (n=2) and similar results were obtained. 
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Figure 41.Free radical scavenging activity of 2 mg/ml of the methanolic extract of 
Salvadora persica in absolute ethanol using DPPH particles. Ascorbic acid is used as a 
positive control due to its high free radical scavenging activity. Untreated DPPH particles 
are used as a negative control. The horizontal axis represents the used samples and 
controls. The vertical axis represents the percentages of free radical scavenging activity 
percentages. This is a representative experiment of two experiments (n=2). 
 
4.3.1 Cytotoxic activity of Artemisia annua 
     Using extraction procedures previously mentioned in Chapter 3, the methanolic 
extract of Artemisia annua had a concentration of 10.2 mg/ml. Using the LDH 
Cytotoxicity Detection Kit, 100 µg/ml and 200 µg/ml of the dry residue of Artemisia 
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annua extract in DMEM were tested for cytotoxic activity against Human Lung 
Fibroblasts and Human Embryonic Kidney cells. The experiment was done as described 
in Chapter 3. Figure 42 shows the results of this experiment in terms of cytotoxicity 
percentage.       
 
Figure 42.Percentages of cytotoxicity of Artemisia annua extract against Human Lung 
Fibroblasts and Human Embryonic Kidney cell lines using the LDH Cytotoxicity Detection 
Kit. The horizontal axis represents the used samples and controls. The vertical axis 
represents the percentages of cytotoxicity. Triton is used as a positive control, because 
it has a potent cytotoxic activity. Untreated cells are used as a negative control. This is a 
representative experiment of two experiments (n=2). 
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     As shown in Figure 42, the methanolic extract of Artemisia annua had no significant 
cytotoxic activity against the two cell lines used in this experiment, Human Lung 
Fibroblasts and Human Embryonic Kidney cells. To confirm these results, the same 
concentrations were tested for their effect on cell viability of the same cell lines, using 
the alamarBlue indicator. Figure 43 shows the results of this experiment in terms of cell 
viability percentages.  
 
Figure 43.Percentages of cell viability of Human Lung Fibroblasts and Human Embryonic 
Kidney cell treated with the extract of Artemisia annua after 3 hours of incubation with 
the alamarBlue reagent. The horizontal axis represents the used samples and controls. 
The vertical axis represents the percentages of cell viability. DMSO is used as a positive 
control, because it has a potent cytotoxic activity. Untreated cells are used as a negative 
control. This is a representative experiment of two experiments (n=2). 
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     As shown in figure 43, Human Lung Fibroblasts were not affected at all by the two 
concentrations of the Artemisia annua extract tested. However, the two concentrations 
affected the cell viability of Human Embryonic Kidney cells to some extent. Relative to 
the effect of 70% DMSO, 82% of cell viability might not be considered as a potent 
cytotoxic effect. These two experiments were repeated (n=2) and similar results were 
obtained.   
4.3.2 Antibacterial activity of Artemisia annua  
     Disk Diffusion assay was performed to see if 300 mg/ml of Artemisia annua extract in 
8% DMSO had any antibacterial activity against Escherichia coli. The agar plate was 
imaged after 24 hours, 48 hours and 72 hours of incubation. Figure 44 shows the results 
of the Disk Diffusion assay. 
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Figure 44.Disk diffusion assay for 300 mg/ml of Artemisia annua extract in 8% DMSO. 
The images were taken after: (A) 24 hour incubation, (B) 48 hour incubation and 
(C) 72 hour incubation. In each picture, the upper disc serves as a control 
(ampicillin). The lower right disk serves as a vehicle control (8% DMSO) and the 
lower left disk contains the extract. This is a representative experiment of two 
experiments (n=2).  
 
          Figure 44 shows that there was a little antibacterial activity of 300 mg/ml of 
Artemisia annua noticed against Escherichia coli. This experiment was repeated (n=2) 
and similar results were obtained.  
4.4 Free radical scavenging activity of Artemisia annua  
     The test for radical scavenging activity was performed using DPPH particles dissolved 
in ethanol as described in chapter 3. A concentration of 2 mg/ml of each extract of the 
plant in absolute ethanol was tested for free radical scavenging activity. A concentration 
of 50 µg/ml of ascorbic acid in absolute ethanol was used as a positive control. Figure 45 
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shows the results of this experiment in terms of radical scavenging activity. As shown in 
the figure, the extract of Artemisia annua showed only 25% free radical scavenging 
activity. This experiment was repeated (n=2) and similar results were obtained.    
 
 
Figure 45.Free radical scavenging activity of 2 mg/ml of the extract of Artemisia annua in 
absolute ethanol. The horizontal axis represents the used samples and controls. The 
vertical axis represents the percentages of free radical scavenging activity. Ascorbic acid 
is used as a positive control, because it has a potent free radical scavenging activity. 
Untreated cells are used as a negative control. This is a representative experiment of 
two experiments (n=2). 
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Chapter 5 
Conclusion and Summary 
     As mentioned in Chapter 2, several medicinal plants have been used as medicines in 
the Arabian Peninsula throughout history. In this thesis project, an attempt to find the 
cytotoxic, antibacterial and free radical scavenging activities of three of the most 
commonly used medicinal plants in Saudi Arabia was the focus of this investigation. 
Further fractionation and screening work is required to isolate bioactive metabolites 
from the crude extracts of these plants. 
 
     As shown in Chapter 4, the methanolic extract of Matricaria chamomilla possesses 
significant antibacterial activity against Escherichia coli. The minimum effective 
concentration of this extract was 50 mg/ml, which is relatively low compared to other 
crude extracts. When individual solvent fractions obtained from the crude extract were 
screened for antibacterial activity against the same microorganism, all the solvent 
fractions showed mild antibacterial activities, suggesting that there are several 
compounds having several degrees of polarities responsible for the antibacterial activity 
of the crude extract of the plant against Escherichia coli. It can be concluded that these 
compounds work in a synergistic or an additive manner when combined in the crude 
extract.   
 
      The crude methanolic extract showed significant free radical scavenging activity. In 
terms of percentage, that activity was really close to the radical scavenging activity of 
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ascorbic acid, which is a potent anti-oxidant compound. Hexane and methanol fractions 
obtained from that crude extract showed lower percentages of free radical scavenging 
activity individually, which again suggests that the free radical scavenging activity of the 
crude extract of Matricaria chamomilla is not caused by a single compound. Hexane and 
methanol have different degrees of polarity [82]. This suggests that the compounds 
responsible for that type of activity are of different polarities and consequently different 
structures. The compounds having this activity might be working in synergy when 
combined in the crude extract. In addition, the high free radical scavenging activity of 
the methanol extract of Matricaria chamomilla might explain the results of its effect on 
cell viability. As shown in Chapter 4, the cells treated with this extract showed growth 
and increases in numbers beyond the untreated controls. These results suggest that the 
extract acts as a cytoprotective agent. This suggestion can be explained by the 
significant free radical scavenging activity possessed by this extract. This free radical 
scavenging activity of the extract might be providing protection from damaging particles 
and radicals and thus, promoting cell growth and differentiation. Future work is 
required to isolate the solvent fractions and the molecules that might be responsible for 
this effect on cell lines, because cytoprotective agents are very important in the medical 
field now.    
 
     Further screening of the crude extract of Matricaria chamomilla for antibacterial 
activity against different strains of pathogenic bacteria is required. In addition, further 
fractionation using high performance liquid chromatography (HPLC) and liquid  
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chromatography – mass spectrometry (LC-MS) will be required to isolate and find out 
the molecules responsible for the antibacterial and the radical scavenging activities. By 
repeating fractionation, and screening fractions resulting from each fractionation stage 
for biological activity, the molecules responsible for the desired biological activities can 
be isolated. Proton and Carbon nuclear magnetic resonance (NMR) can be used to 
detect the chemical structures of these compounds and find out if any new compounds 
with the desired activities exist.     
 
      The crude extract of Salvadora persica did not show promising antibacterial activity 
against Escherichia coli despite the fact that the methanolic extracts of Salvadora 
persica showed antibacterial activity against Staphylococcus aureus (MIC value of 6.25 
mg/ml), Streptococcus mutans (MIC value of 3.12 mg/ml), Strep. Faecalis (MIC value of 
1.56 mg/ml), Strep. Pyogenic (MIC value of 1.3.12 mg/ml), and Candida albicans (MIC 
value of 6.25 mg/ml) in previous studies. [61] These results suggest that not all bacterial 
strains might be sensitive to the same extract. An extract might be effective against 
some strains due to some mechanisms of action that do not affect other strains. On the 
other side, the extract of Artemisia annua showed a little antibacterial activity against 
Escherichia coli. This little activity might be caused by a small concentration of an active 
molecule. Further screening for antibacterial activity against different strains of bacteria 
and using higher concentrations of the crude extract of Artemisia annua is required to 
confirm these results.  
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     The crude extracts of Salvadora persica and Artemisia annua did not show promising 
cytotoxic or radical scavenging activities. However, further work is required to confirm 
the absence of these two activities in these plants. For example, using a different 
solvent of a different degree of polarity for extracting the plant material might be useful 
in this case, because cytotoxic and free radical scavenging compounds that are not 
soluble in methanol could exist in these two plants. In addition, other cell lines should 
be used to test for cytotoxic activity by these two plants. Other cell viability and 
cytotoxicity assays can be performed for this type of screening in the future. In general, 
this thesis project can be considered as further progress in the journey of drug discovery 
from plants.         
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